AmeriCann (ACAN) S-1 12 Apr 18 2017 Q1 IPO registration Financial data

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
	Dec. 31, 2017	Apr. 06, 2018
Document Information [Line Items]
Entity Registrant Name	Americann, Inc.
Entity Central Index Key	1,508,348
Trading Symbol	acan
Current Fiscal Year End Date	--09-30
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding (in shares)		19,366,000
Document Type	S1
Document Period End Date	Dec. 31, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q1
Amendment Flag	false

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Sep. 30, 2017	Sep. 30, 2016
Current Assets:
Cash and cash equivalents	$ 1,627	$ 24
Interest receivable		2,521
Current portion of prepaid land lease	57,959
Prepaid expenses and other current assets	5,000	11,726
Note receivable		247,378
Total current assets	64,586	261,649
Land held for sale	1,611,312	2,250,809
Construction in progress	680,028
Furniture and equipment	4,153	5,276
Website development costs	12,680	26,514
Notes and other receivables (net of allowance of $469,699)	780,315	780,315
Note receivable - related party	125,327	57,693
Prepaid land lease and related deposits, net of current portion	2,782,047	925,000
Security deposit	3,110	3,110
Total assets	6,063,558	4,310,366
Current Liabilities:
Accounts payable and accrued expenses	624,623	385,380
Interest payable	86,253	118,749
Other payables	19,699	14,927
Notes payable	1,070,000	1,157,997
Total current liabilities	1,800,575	1,677,053
Notes payable - related party	1,978,683	2,024,297
Total liabilities	3,779,258	3,701,350
Commitments and contingencies - see Note 10
Stockholders' Equity:
Preferred stock, $0.0001 par value; 20,000,000 shares authorized; no shares issued and outstanding	0	0
Common stock	1,937	1,703
Additional paid in capital	10,959,188	6,512,244
Accumulated deficit	(8,676,825)	(5,904,931)
Total stockholders' equity	2,284,300	609,016
Total liabilities and stockholders' equity	$ 6,063,558	$ 4,310,366

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - USD ($)	Dec. 31, 2017	Sep. 30, 2017	Sep. 30, 2016
Furniture and equipment, accmulated depreciation	$ 3,985	$ 3,704	$ 2,581
Website development costs, accumulation amortization	32,278	28,820	14,986
Notes and other receivables, allowance	469,699	469,699	469,699
Interest payable, related parties	106,596	84,998	109,825
Notes payable discount	843,452	0	35,250
Note payable, related party, discount	$ 41,696	$ 47,037	$ 72,651
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	20,000,000	20,000,000	20,000,000
Preferred stock, shares issued (in shares)	0	0	0
Preferred stock, shares outstanding (in shares)	0	0	0
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	100,000,000	100,000,000	100,000,000
Common stock, shares issued (in shares)	19,366,000	19,366,000	17,031,000
Common stock, shares outstanding (in shares)	19,366,000	19,366,000	17,031,000

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Revenues:
Consulting fees	$ 40,000	$ 60,000
Total revenues	40,000	60,000
Operating expenses:
Advertising and marketing	10,712	21,312
Professional fees	415,173	571,141
General and administrative expenses	1,412,314	583,739
Provision for doubtful accounts		13,229
Impairment of long-lived assets	639,497	0
Total operating expenses	2,477,696	1,189,421
Loss from operations	(2,437,696)	(1,129,421)
Other income (expense):
Interest income	11,086	183,255
Interest expense	(201,367)	(162,834)
Loss on extinguishment of debt		(991,939)
Interest expense - related party	(143,917)	(109,825)
Total other income (expense)	(334,198)	(1,081,343)
Net loss	$ (2,771,894)	$ (2,210,764)
Basic and diluted loss per common share (in dollars per share)	$ (0.15)	$ (0.13)
Weighted average common shares outstanding (in shares)	19,007,371	17,031,000

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Equity - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balances (in shares) at Sep. 30, 2015		16,631,000
Balances at Sep. 30, 2015		$ 1,663	$ 5,007,497	$ (3,694,167)	$ 1,314,993
Stock-based compensation expense			131,075		131,075
Stock option expense			9,173		9,173
Stock issued for debt modification (in shares)		400,000
Stock issued for debt modification		$ 40	1,364,499		1,364,539
Net loss				(2,210,764)	$ (2,210,764)
Balances (in shares) at Sep. 30, 2016		17,031,000			17,031,000
Balances at Sep. 30, 2016		$ 1,703	6,512,244	(5,904,931)	$ 609,016
Stock-based compensation expense			37,450		37,450
Stock option expense			222,988		222,988
Net loss				(2,771,894)	(2,771,894)
Shares and warrants issued to lessor (in shares)		100,000
Shares and warrants issued to lessor		$ 10	1,972,956		$ 1,972,966
Stock issued for options exercised (in shares)		50,000			50,000
Stock issued for options exercised		$ 5	37,495		$ 37,500
Stock issued for cash, net (in shares)		2,185,000
Balances (in shares) at Sep. 30, 2017		19,366,000			19,366,000
Balances at Sep. 30, 2017		$ 1,937	10,959,188	(8,676,825)	$ 2,284,300
Stock issued for cash, net		$ 219	$ 2,176,055		2,176,274
Net loss					$ (1,374,364)
Balances (in shares) at Dec. 31, 2017					19,366,000

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Cash flows from operating activities:
Net loss	$ (2,771,894)	$ (2,210,764)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	14,957	14,956
Provision for doubtful accounts		13,229
Stock based compensation and option expense	260,438	140,249
Loss on extinguishment of debt		991,939
Impairment of long-lived assets	639,497	0
Amortization of equity instruments issued to lessor	39,456
Amortization of debt discount/(premium)	9,636	0
Changes in operating assets and liabilities:
Interest receivable	2,521	3,454
Bank overdraft	10,616
Prepaid expenses	25,230	24,032
Accounts payable and accrued expenses	49,319	300,082
Interest payable	(7,669)	8,924
Interest payable - related party	(24,827)	109,825
Other payables	4,772	3,211
Net cash flows used in operations	(1,747,948)	(600,863)
Cash flows from investing activities:
Additions to construction in progress	(500,720)
Deposit on land	0	(725,000)
Payments received on notes receivable	247,378	338,927
Advances made on notes receivable - related party	(67,634)	(57,693)
Advances made on notes receivable		(128,744)
Net cash flows used in investing activities	(320,976)	(572,510)
Cash flows from financing activities:
Common stock issued for cash, net	2,176,274
Proceeds from exercise of stock options	37,500	0
Proceeds from note payable	104,657	724,544
Proceeds from note payable - related party	0	247,500
Payments on note payable - related party	(20,000)	0
Payments on notes payable	(227,904)	0
Net cash flows provided by financing activities	2,070,527	972,044
Net increase (decrease) in cash and cash equivalents	1,603	(201,329)
Cash and cash equivalents at beginning of period	24	201,353
Cash and cash equivalents at end of period	1,627	24
Supplementary Disclosure of Cash Flow Information:
Cash paid for interest, related parties	396,841	151,925
Cash paid for income taxes	0	0
Non-Cash Investing and Financing Activities:
Shares and warrants issued to lessor as consideration for land lease	1,972,966
Construction in progress expenditures incurred but not yet paid	179,308
Common stock issued for related party debt settlement		500,000
Debt discount on new debt		35,250
Reclass note payable to related party (3rd party debt was released and assumed by related party)		521,297
Debt discount/premium due to debt modification		72,651
Warrants issued with debt modification		$ 756,637

Consolidated Statements of Cas7

Consolidated Statements of Cash Flows (Parentheticals) - USD ($)	12 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Cash paid for interest, related parties	$ 396,841	$ 151,925
Related Parties [Member]
Cash paid for interest, related parties	$ 194,358	$ 194,358

Consolidated Balance Sheets (Cu

Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Dec. 31, 2017	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2015
Current Assets:
Cash and cash equivalents	$ 732,355	$ 1,627	$ 24	$ 201,353
Restricted cash	365,480
Current portion of prepaid land lease	57,959	57,959
Prepaid expenses and other current assets	5,000	5,000	11,726
Total current assets	1,160,794	64,586	261,649
Land held for sale		1,611,312	2,250,809
Construction in progress	681,181	680,028
Furniture and equipment	3,872	4,153	5,276
Website development costs	9,222	12,680	26,514
Notes and other receivables (net of allowance of $469,699)	782,130	780,315	780,315
Note receivable - related party	131,589	125,327	57,693
Prepaid land lease and related deposits, net of current portion	2,767,557	2,782,047	925,000
Security deposit	3,110	3,110	3,110
Total assets	5,539,455	6,063,558	4,310,366
Current Liabilities:
Accounts payable and accrued expenses	429,320	624,623	385,380
Interest payable	115,337	86,253	118,749
Other payables	11,913	19,699	14,927
Notes payable	440,862	1,070,000	1,157,997
Total current liabilities	997,432	1,800,575	1,677,053
Notes payable - related party	1,973,342	1,978,683	2,024,297
Total liabilities	2,970,774	3,779,258	3,701,350
Commitments and contingencies - see Note 10
Stockholders' Equity:
Preferred stock, $0.0001 par value; 20,000,000 shares authorized; no shares issued and outstanding	0	0	0
Common stock	1,937	1,937	1,703
Additional paid in capital	12,617,933	10,959,188	6,512,244
Accumulated deficit	(10,051,189)	(8,676,825)	(5,904,931)
Total stockholders' equity	2,568,681	2,284,300	609,016
Total liabilities and stockholders' equity	$ 5,539,455	$ 6,063,558	$ 4,310,366

Consolidated Balance Sheets (C9

Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($)	Dec. 31, 2017	Sep. 30, 2017	Sep. 30, 2016
Furniture and equipment, accmulated depreciation	$ 3,985	$ 3,704	$ 2,581
Website development costs, accumulation amortization	32,278	28,820	14,986
Notes and other receivables, allowance	469,699	469,699	469,699
Interest payable, related parties	106,596	84,998	109,825
Notes payable discount	843,452	0	35,250
Note payable, related party, discount	$ 41,696	$ 47,037	$ 72,651
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	20,000,000	20,000,000	20,000,000
Preferred stock, shares issued (in shares)	0	0	0
Preferred stock, shares outstanding (in shares)	0	0	0
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	100,000,000	100,000,000	100,000,000
Common stock, shares issued (in shares)	19,366,000	19,366,000	17,031,000
Common stock, shares outstanding (in shares)	19,366,000	19,366,000	17,031,000

Consolidated Statements of Op10

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Revenues:
Consulting fees		$ 15,000
Total revenues		15,000
Operating expenses:
Advertising and marketing	962	2,247
Professional fees	151,987	150,404
General and administrative expenses	434,862	288,433
Provision for doubtful accounts		3,325
Total operating expenses	587,811	444,409
Loss from operations	(587,811)	(429,409)
Other income (expense):
Interest income	8,077	27,187
Interest expense	(754,379)	(81,575)
Other income (expense)	(2,861)
Interest expense - related party	(37,390)	(32,968)
Total other income (expense)	(786,553)	(87,356)
Net loss	$ (1,374,364)	$ (516,765)
Basic and diluted loss per common share (in dollars per share)	$ (0.07)	$ (0.03)
Weighted average common shares outstanding (in shares)	19,366,000	18,286,435

Consolidated Statements of Ca11

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Cash flows from operating activities:
Net loss	$ (1,374,364)	$ (516,765)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	3,739	3,740
Provision for doubtful accounts		3,325
Stock based compensation and option expense	171,307	18,725
Loss on disposal of land	2,861
Amortization of equity instruments issued to lessor	14,490
Amortization of debt discount/(premium)	708,645	21,668
Changes in operating assets and liabilities:
Interest receivable	(8,077)	2,521
Amounts due from WGP		(12,108)
Prepaid expenses		13,477
Accounts payable and accrued expenses	(178,215)	(233,708)
Interest payable	50,682	(8,924)
Interest payable - related party	(21,598)	(109,825)
Other payables	1,891	1,354
Deferred revenue		30,000
Net cash flows used in operations	(628,639)	(786,520)
Cash flows from investing activities:
Additions to construction in progress	(1,153)
Payments received on notes receivable		86,231
Advances made on notes receivable - related party		(64,993)
Advances made on notes receivable		(15,000)
Net cash flows used in investing activities	(1,153)	6,238
Cash flows from financing activities:
Common stock issued for cash, net		1,806,274
Proceeds from note payable	1,726,000	24,657
Payments on note payable - related party		(20,000)
Payments on notes payable		(227,904)
Net cash flows provided by financing activities	1,726,000	1,583,027
Net increase in cash, cash equivalents, and restricted cash	1,096,208	802,745
Cash, cash equivalents, and restricted cash at beginning of period	1,627	24
Cash, cash equivalents, and restricted cash at end of period	1,097,835	802,769
Supplementary Disclosure of Cash Flow Information:
Cash paid for interest, related parties	54,040	164,450
Cash paid for income taxes	0	0
Non-Cash Investing and Financing Activities:
Shares and warrants issued to lessor as consideration for land lease		1,770,333
Proceeds from sale of land used to satisfy debt obligations	1,608,451
Debt discount related to warrants issued with debt and beneficial conversion feature	$ 1,536,000

Note 1 - Description of Busines

Note 1 - Description of Business and Significant Accounting Policies	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017
Notes to Financial Statements
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]	NOTE 1. AmeriCann, Inc. ("the Company", “we”, “our” or "the Issuer") was organized under the laws of the State of Delaware on June 25, 2010. On January 17, 2014, 93% The Company's business plan is to offer a comprehensive, turnkey package of services that includes consulting, design, construction and financing to approved and licensed marijuana operators throughout the United States. The Company's business plan is based on the anticipated growth of the regulated marijuana market in the United States. The Company's activities are subject to significant risks and uncertainties including failure to secure funding to properly expand its operations. Basis of Presentation The (a) balance sheet as of September 30, 2017, three December 31, 2017 2016, 10 December 4, 2017. not 2017 10 Certain prior period amounts have been reclassified to conform with current period presentation. These reclassifications have no Restricted Cash The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts in the consolidated statements of cash flows: December 31, September 30, 2017 Cash and cash equivalents $ 732,355 $ 1,627 Restricted cash 365,480 - Total cash, cash equivalents, and restricted cash shown in the cash flow statement $ 1,097,835 $ 1,627 Amounts included in restricted cash represent those required to be set aside by a contractual agreement with a lender for the payment of specific construction related expenditures as part of the Company’s property development in Massachusetts. See Notes 5 10. Recent Accounting Pronouncements In July 2017, No. 2017 11, 260 480 815 no December 15, 2018, In May 2017, No. 2017 09, 718 1 2 718, 718. December 15, 2017, not In February 2017, No. 2017 05, 610 20 610 20, 610 20, May 2014 No. 2014 09, 606 December 15, 2017, No. 2014 09, In January 2017, No. 2017 03, 250 No. 2014 09, 606 No. 2016 02, 842 No. 2016 13, 326 not No. 2014 09 Between May 2014 December 2016, 606 five may December 15, 2017, not In November 2016, No. 2016 18, 230 December 15, 2017, first October 1, 2017. no In February 2016, No. 2016 02, 842 2016 02” 2016 02 2016 02, 12 2016 02 December 15, 2018 ( 2016 02	NOTE 1. Description of Business AmeriCann, Inc. ("the Company", “we”, “our”, or "the Issuer") was organized under the laws of the State of Delaware on June 25, 2010. On January 17, 2014, 93% The Company's new business plan is to offer a comprehensive, turnkey package of services that includes consulting, design, construction and financing to approved and licensed marijuana operators throughout the United States. The Company's business plan is based on the anticipated growth of the regulated marijuana market in the United States. The Company's activities are subject to significant risks and uncertainties including failure to secure funding to expand its operations. Certain prior period amounts have been reclassified to conform with current period presentation. These reclassifications have no All significant intercompany balances and transactions have been eliminated in the consolidated financial statements. Summary of Significant Accounting Policies This summary of significant accounting policies of the Company is presented to assist in understanding the Company’s consolidated financial statements. The consolidated financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States and have been consistently applied in the preparation of the consolidated financial statements. Principles of Consolidation The consolidated financial statements include the accounts of AmeriCann, Inc. and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in the consolidated financial statements. Use of Estimates The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The more significant estimates and assumptions made by management are valuation of equity instruments, deferred tax asset valuation and allowance and collectability of long-lived assets. Actual results could differ from those estimates as the current economic environment has increased the degree of uncertainty inherent in these estimates and assumptions. See Note 3 Cash and Cash Equivalents Cash and cash equivalents includes cash on hand, demand deposit accounts and temporary cash investments with maturities of ninety Income Taxes In accordance with ASC Topic 740, not not We expect to recognize the financial statement benefit of an uncertain tax position only after considering the probability that a tax authority would sustain the position in an examination. For tax positions meeting a "more-likely-than- not" not no September 30, 2017, no no not Concentration of Credit Risks and Significant Customers Financial instruments that potentially subject us to concentrations of credit risk consist principally of cash, notes receivables, deposits, accounts receivables and notes receivable. We place our cash with high credit quality financial institutions. As of September 30, 2017, $125,327 $1,250,014 $469,699 3 For the years ended September 30, 2017 2016, one 4900 Financial Instruments and Fair Value of Financial Instruments We adopted ASC Topic 820, 820 ASC Topic 820 820 Level 1: Observable inputs such as quoted market prices in active markets for identical assets or liabilities Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data Level 3: Unobservable inputs for which there is little or no The carrying value of financial assets and liabilities recorded at fair value is measured on a recurring or nonrecurring basis. Financial assets and liabilities measured on a non-recurring basis are those that are adjusted to fair value when a significant event occurs. We had no no Derivative Liabilities We evaluate stock options, stock warrants or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for under the relevant sections of ASC Topic 815 40, 815 40 none September 30, 2017 2016. Long-Lived Assets Our long-lived assets consisted of property, equipment and real estate and are reviewed for impairment in accordance with the guidance of the Topic ASC Topic 360, 205, may not third September 30, 2017, $639,497 no September 30, 2016. Property and Equipment Property and equipment are stated at cost. Depreciation of property and equipment is provided using the straight-line method for financial reporting purposes at rates based on the estimated useful lives of the assets. Estimated useful lives range from three seven 360 45. Construction in progress (CIP) CIP consists of initial costs associated with the construction of our medical cannabis center, including interest expenses. When CIP is finished the asset will be transferred to property and equipment. No Capitalized Interest The Company capitalizes interest to construction in progress made in connection with medical center cannabis construction that are not $28,697 $0 September 30, 2017, 2016, Equity Instruments Issued to Non-Employees for Acquiring Goods or Services Issuances of our common stock or warrants for acquiring goods or services are measured at the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. The measurement date for the fair value of the equity instruments issued to consultants or vendors is determined at the earlier of (i) the date at which a commitment for performance to earn the equity instruments is reached (a "performance commitment" which would include a penalty considered to be of a magnitude that is a sufficiently large disincentive for nonperformance) or (ii) the date at which performance is complete. Although situations may may not Non-Cash Equity Transactions Shares of equity instruments issued for noncash consideration are recorded at the estimated fair market value of the consideration granted based on the estimated fair market value of the equity instrument, or at the estimated fair market value of the goods or services received, whichever is more readily determinable. Stock-Based Compensation We account for share-based awards to employees in accordance with ASC Topic 718, 505 50, Related Parties A party is considered to be related to us if the party directly or indirectly or through one may one one one one Revenue Recognition We recognize revenue when (i) persuasive evidence of an arrangement exists; (ii) the fee is fixed or determinable; (iii) performance of service has been delivered; and (iv) collection is reasonably assured. Advertising Expense Advertising, promotional and selling expenses consisted of sales and marketing expenses, and promotional activity expenses. Expenses are recognized when incurred. General and Administrative Expense General and administrative expenses consisted of professional service fees, rent and utility expenses, meals, travel and entertainment expenses, and other general and administrative overhead costs. Expenses are recognized when incurred. Loss per Share We compute net loss per share in accordance with the ASC Topic 260. Basic loss per share amounts is computed by dividing the net loss by the weighted average number of common shares outstanding. Shares issuable upon the exercise of equity instruments such as warrants and options were not Recently Adopted Accounting Pronouncements In August 2014, No. 2014 15, 205 40 January 1, 2017; not 2 Recently Issued Accounting Pronouncements Between May 2014 December 2016, 606 five may December 15, 2017, not 2018. In February 2016, No. 2016 02, 842 842 not December 15, 2018, may In March 2016, No. 2016 09, 718 1 2 3 December 15, 2016, In August 2016, No. 2016 15, 230 December 15, 2017, In November 2016, No. 2016 18, 230 December 15, 2017, not In January 2017, No. 2017 03, 250 No. 2014 09, 606 No. 2016 02, 842 No. 2016 13, 326 In March 2017, No. 2017 08, 310 20 December 15, 2018. In February 2017, No. 2017 05, 610 20 610 20, 610 20, May 2014 No. 2014 09, 606 December 15, 2017, No. 2014 09, In May 2017, No. 2017 09, 718 1 2 718, 718. December 15, 2017, not In July 2017, No. 2017 11, 260 480 815 no December 15, 2018,

Note 2 - Going Concern

Note 2 - Going Concern	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017
Notes to Financial Statements
Substantial Doubt about Going Concern [Text Block]	NOTE 2. The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates, among other things, the realization of assets and satisfaction of liabilities in the normal course of business. The Company had an accumulated deficit of $10,051,189 $8,676,825 December 31, 2017 September 30, 2017, $1,374,364 three December 31, 2017. $1,251,829 $469,699 may not may not April 7, 2017. no not January 18, 2018, $1,045,000 18% April 18, 2015 January 18, 2018 $523,023. $1,568,023, not Management believes that the actions presently being taken to further implement its business plan and generate additional revenues provide the opportunity for the Company to continue as a going concern. While the Company believes in the viability of its strategy to generate additional revenues and in its ability to raise additional funds, there can be no not	NOTE 2. The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates, among other things, the realization of assets and satisfaction of liabilities in the normal course of business. The Company had an accumulated deficit of $8,676,825 $5,904,931 September 30, 2017 2016, $2,771,894 September 30, 2017 $1,735,989. $1,250,014 $469,699 may not may not April 7, 2017. January 8, 2018. To date, the Company has funded its operations primarily by way of the sale of equity securities, convertible note financing, short term financing from private parties, and advances from related parties. The Company currently needs to raise additional capital in order to fund operations, maintain the land lease agreement, as well as to make payments on existing liabilities. The Company is continuing to raise capital, as it did during the year ended September 30, 2017, $7 twelve September 1, 2017, $10,000,000 $20,000,000. October 5, 2017, $1,760,000. October 30, 2017 $800,000 three no may not

Note 3 - Notes Receivables

Note 3 - Notes Receivables	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017
Notes to Financial Statements
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]	NOTE 3. Notes and other receivables as of December 31, 2017 September 30, 2017, December 31, September 30, 2017 Notes and other receivables from WGP, a licensed medical marijuana cultivator; $673,294 note secured by real and personal property of the borrower, interest rate of 18.0%; accrued consulting fees of $40,000, construction advances of $332,357 and accrued interest of $206,178. Net of reserves of $469,699. All amounts are due and payable immediately. 782,130 780,315 Related party note receivable from CCI, a non-profit corporation, financing of up to $2.5 million through April 2021, interest rate of 18.0%; monthly principal and interest payments commencing the sixth month after CCI begins to generate sales; construction and working capital advances of $119,635, and accrued interest of $11,954; unsecured. 131,589 125,327 $ 913,719 $ 905,642 The notes and other receivables from WGP are classified as long term due to ongoing disputes between the Company and WGP. The Company recently won an arbitration hearing against WGP, but will not	NOTE 3. Notes and Other Receivables consisted of the following: September 30, September 30, 2016 Note receivable from 4900 Jackson, LLC, a licensed dispensary, interest rate of 12.0%; monthly principal and interest payments of $50,000, with a balloon payment of $182,531 due on May 1, 2017; collateralized by the borrower's assets. $ - $ 247,378 Notes and other receivables from WGP, a licensed medical marijuana cultivator; $673,294 note secured by real and personal property of the borrower, interest rate of 18.0%; accrued consulting fees of $40,000, construction advances of $332,357 and accrued interest of $204,363. Net of reserves of $469,699. All amounts are due and payable immediately. 780,315 780,315 Related party note receivable from CCI, a non-profit corporation, financing of up to $2.5 million through April 2021, interest rate of 18.0%; monthly principal and interest payments commencing the sixth month after CCI begins to generate sales; construction and working capital advances of $119,635, and accrued interest of $5,692; unsecured. 125,327 57,693 905,642 1,085,386 Less: Current portion - 247,378 $ 905,642 $ 838,008 The notes and other receivables from WGP are classified as long term due to ongoing disputes between the Company and WGP. We filed a Demand for Arbitration against WGP on April 7, 2017. January 8, 2018.

Note 4 - Land Held for Sale

Note 4 - Land Held for Sale	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017
Land [Member]
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	NOTE 4. On July 31, 2014, five 4200 $2,250,809. October 5, 2017, $1,760,000 third September 30, 2017 $1,611,312, September 30, 2017 $1,611,312. The land sale was completed on December 4, 2017 $2,861 December 31, 2017 $990,000 $17,088 $601,363 $800,000 second	NOTE 4. On July 31, 2014, five $2,250,000. $990,000 March 15, 2018. 5 October 5, 2017, $1,760,000 $639,497 September 30, 2017 $1,611,312, September 30, 2017 $1,611,312.

Note 5 - Notes Payable

Note 5 - Notes Payable	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017
Notes to Financial Statements
Debt Disclosure [Text Block]	NOTE 5. Unrelated The Company maintained a loan secured by a first five December 31, 2017, $990,000 4. On August 25, 2017, $150,000. 12% May 31, 2018. December 31, 2017, $89,677 $4,311. $3,057 $0 three December 31, 2017 2016, Convertible loans On October 5, 2017, $128,000 12% October 5, 2018. April 5, 2018 may 15% 35%. April 5, 2018, may not April 5, 2018, $1.35, 1 65 2 $1.00, $1.35, 1 2 two fifteen $3,000 December 31, 2017. not no December 31, 2017. $750 $0 three December 31, 2017 2016, On November 13, 2017, $68,000 12% November 13, 2018. May 13, 2018 may 15% 35%. May 13, 2018, may not May 13, 2018, $1.35, 1 65 2 $1.00, $1.35, 1 2 two fifteen $3,000 December 31, 2017. not no December 31, 2017. $500 $0 three December 31, 2017 2016, Construction loan On October 30, 2017 $800,000 three first 3 Nov 17, 2017, The loan bears interest at 8% April 30, 2018. $1.50, may 5 As further consideration for the loan, the Company issued warrants to the Lenders which allow the Lenders to purchase up to 660,000 $1.50 October 30, 2022. 660,000 $442,388 $357,612 As described in Note 4, December 4, 2017, $601,363 not $712,736 $0 three December 31, 2017 2016, Convertible Note Offering On December 29, 2017 $800,000 8% December 31, 2018. may $1.50 The note holders also received warrants which entitle the note holders to purchase up to 533,333 $1.50 October 17, 2022. GVC Capital LLC acted as the placement agent for the offering and received a cash commission of $64,000, 106,667 $1.50 December 29, 2022. The Company allocated the proceeds between the note and the warrants based on their relative fair values. The relative fair value of the 640,000 $607,024 $128,976 In connection with the offering, the Company paid fees of $64,000 $48,562 $15,438, All debt discounts are being recognized on a straight-line basis over the terms of the notes. As the transaction occurred just prior to the quarter end, no December 31, 2017. Related Party On February 1, 2016, $200,000. May 1, 2016, $1,000,000. July 14, 2016, $521,297 $2,431,646. one On July 14, 2016, two Of the amounts owed to SCP, $500,000 400,000 $1.25 The remaining $1,931,646 two The first $1,000,000, 9.5% December 31, 2019. $1.25 not If the average closing price of our common stock is at least $2.50 twenty twenty 100,000 may, 10 twenty 45 The second $931,646, 8% December 31, 2019. not first December 31, 2019. Accrued interest on these notes payable was $106,596 $84,998 December 31, 2017 2016, In connection with the debt modification agreement, we issued SCP warrants to purchase 800,000 $1.50 800,000 $3.00 June 30, 2020. $72,651 December 31, 2017, $1,931,646, $41,696. $5,341 $9,763 three December 30, 2017 2016.	NOTE 5. Unrelated On September 15, 2015, $900,000. 12% March 16, 2016. $650,000 April 6, 2016, $990,000, 18% March 15, 2017. 470 50, $90,000 September 30, 2016. March 15, 2017, March 15, 2018, 18% may $188,100 $150,497 September 30, 2017 2016, As of September 30, 2016, $203,247 8% 18%, December 14, 2016, January 15, 2017, $75,000 $0.75. 75,000 $0.75 75,000 $1.25 September 15, 2020. $35,250 $35,250 September 30, 2017, $24,657 $227,904. September 30, 2017, $0. September 30, 2017, no no $4,267 $12,337 September 30, 2017 2016, On August 25, 2017, $150,000. 12% May 31, 2018. September 30, 2017, $80,000. September 30, 2017, $1,255. $1,255 $0 September 30, 2017 2016, Related Party On February 1, 2016, $200,000. May 1, 2016, $1,000,000. July 14, 2016, $521,297 $2,431,646. one On July 14, 2016, two Of the amounts owed to SCP, $500,000 400,000 $1.25 The remaining $1,931,646 two The first $1,000,000, 9.5% December 31, 2019. $1.25 not September 30, 2017, $47,630. If the average closing price of our common stock is at least $2.50 twenty twenty 100,000 may, 10 twenty 45 The second $931,646, 8% December 31, 2019. not second first December 31, 2019. September 30, 2017, $37,368. The Company analyzed the modification of the note under ASC Topic 470, $901,939 September 30, 2016. In connection with the debt modification agreement, we issued SCP warrants to purchase 800,000 $1.50 800,000 $3.00 June 30, 2020. 9 $72,651 At September 30, 2017, $1,978,683, $47,037. $25,614 $0 September 30, 2017 2016,

Note 6 - Related Party Transact

Note 6 - Related Party Transactions	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	NOTE 6. Strategic Capital Partners. December 31, 2017 September 30, 2017, $1,931,646 $1,978,683, Interest expense was $37,390 $32,968 three December 31, 2017 2016, $106,596 $84,998 December 31, 2017 September 30, 2017, $21,133 December 31, 2017. Coastal Compassion. April 7, 2016, one Pursuant to the agreements, we agreed to provide CCI with financing of up to $2.5 five 18% three April 1, 2016, $10,000 not As of December 31, 2017, $131,589, $119,635, $11,954.	NOTE 6. Strategic Capital Partners. September 30, 2017 2016, $1,978,683 $2,024,297, July 14, 2016, $500,000 400,000 $1,931,646 two 5 9. Interest expense was $143,917 $109,825 September 30, 2017 2016, $84,998 $109,825 September 30, 2017 September 30, 2016, 2017, $194,358, $20,000, no 2016, $247,500 no Coastal Compassion. April 7, 2016, one Pursuant to the agreements, we agreed to provide CCI with financing of up to $2.5 five 18% three April 1, 2016, $10,000 not six not As of September 30, 2017, $125,327, $119,635, $5,692.

Note 7 - Earnings Per Share

Note 7 - Earnings Per Share	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017
Notes to Financial Statements
Earnings Per Share [Text Block]	NOTE 7. The following table sets forth the computation of basic and diluted net loss per share: Three Months Ended December 31, 2017 2016 Net loss attributable to common stockholders $ (1,374,364 ) $ (516,765 ) Basic weighted average outstanding shares of common stock 19,366,000 18,236,435 Dilutive effects of common share equivalents - - Dilutive weighted average outstanding shares of common stock 19,366,000 18,236,435 Basic and diluted net loss per share of common stock $ (0.07 ) $ (0.03 ) As of December 31, 2017, 1,305,000 11,566,000 December 31, 2016, 1,205,000 9,981,000	NOTE 7. The following table sets forth the computation of basic and diluted net loss per share: Year Ended September 30, 2017 2016 Net loss attributable to common stockholders $ (2,771,894 ) $ (2,210,764 ) Basic weighted average outstanding shares of common stock 19,007,371 17,031,000 Dilutive effects of common share equivalents - - Dilutive weighted average outstanding shares of common stock 19,007,371 17,031,000 Basic and diluted net loss per share of common stock $ (0.15 ) $ (0.13 ) As of September 30, 2017, 1,305,000 10,166,000 September 30, 2016, 1,205,000 4,341,000

Note 8 - Income Taxes

Note 8 - Income Taxes	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017
Notes to Financial Statements
Income Tax Disclosure [Text Block]	NOTE 8. We did not three December 31, 2017. not December 31, 2017. As of December 31, 2017, not no September 30, 2017.	NOTE 8. Deferred income taxes arise from the temporary differences between financial statement and income tax recognition of net operating losses. These loss carryovers are limited under the Internal Revenue Code should a significant change in ownership occur. The Company accounts for income taxes pursuant to ASC Topic 740. 2015 17, September 30, 2016. Deferred income taxes arise from the temporary differences between financial statement and income tax recognition of net operating losses and other items. Loss carryovers are limited under the Internal Revenue Code should a significant change in ownership occur. The components of the deferred income tax assets and liabilities arising under ASC Topic 740 September 30, 2017 2016 Deferred tax assets $ - $ - Deferred tax liabilities - - Net deferred tax assets/(liabilities) $ - $ - The types of temporary differences between the tax basis of assets and their financial reporting amounts that give rise to a significant portion of the deferred assets and liabilities are as follows: September 30, 2017 2016 Temporary Difference Tax Effect Temporary Difference Tax Effect Deferred tax assets Net operating loss $ 1,789,958 $ 663,358 $ 1,156,331 $ 428,536 Other temporary differences 716,750 265,628 9,261 3,432 Net deferred tax assets 2,506,708 928,986 1,165,592 431,968 Valuation allowance (2,506,708 ) (928,986 ) (1,165,592 ) (431,968 ) Total deferred tax asset - - - - Deferred tax liabilities Total deferred liability - - - - Total net deferred tax asset $ - $ - $ - $ - At September 30, 2017 September 30, 2016, $4,370,404 $2,551,748 2034. $928,986 $431,968 100% September 30, 2017 September 30, 2016 $497,018 $27,396. A reconciliation of the U.S. statutory federal income tax rate to the effective tax rate is as follows: September 30, 2017 2016 U.S. Federal statutory graduated rate 34.00 % 34.00 % State income tax rate, net of federal benefit 3.06 % 3.06 % Total rate 37.06 % 37.06 % Less: Net operating loss for which no benefit is currently available (37.06 )% (37.06 )% Net effective rate 0.00 % 0.00 % The Company’s income tax filings are subject to audit by various taxing authorities. The Company’s open audit periods are September 30, 2015, 2016, 2017.

Note 9 - Equity

Note 9 - Equity	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	NOTE 11. Equity Line Agreement. December 12, 2017, $10,000,000 During the term of the Agreement, the Company, at its sole discretion, may one 10 $500,000. A closing will occur on the date which is no five no seven The amount to be paid by MSC on a particular Closing Date will be determined by dividing the dollar amount specified in the Put Notice by the Purchase Price. The Purchase Price is 90% five no may not The Company may 75% may, not $1.00 The Company is under no The equity line agreement has a term of 18 may December 31, 2017, not Warrants. three December 31, 2017 Weighted Weighted Average Average Contractual Aggregate Number of Exercise Term Intrinsic Shares Price (Years) Value Outstanding and exercisable at September 30, 2017 10,166,000 $ 3.68 2.4 $ - Granted 1,400,000 $ 1.50 4.8 Cancelled - Exercised - Outstanding as of December 31, 2017 11,566,000 $ 3.42 2.4 $ 20,461,100 Vested and expected to vest at December 31, 2017 11,566,000 $ 3.42 2.4 $ 20,461,100 Exercisable at December 31, 2017 7,826,000 $ 5.50 2.2 $ 8,954,500 As disclosed in Notes 5 10, 1,400,000 $1.50 ● Expected term – 3 5 ● Volatility – 163% 176% ● Risk-free rate – 1.73% 2.00% ● Stock price - $1.74 $4.09 ● Expected dividends – $0 For those warrants that were issued with debt, the proceeds were allocated to the respective instruments on a pro rata basis based on the fair value of each instrument. See Note 5.	NOTE 9. Preferred Stock The Company has authorized 20,000,000 $.0001 No September 30, 2017 2016. Common Stock On July 14, 2016, $500,000 400,000 $1.25 5. On November 7, 2016, 2,000,000 $1.00 one one one $3.00 November 4, 2020. 43% $2,000,000 $6,000,000 $193,726 On March 21, 2017, 50,000 50,000 $37,500. During the year ended September 30, 2017, 185,000 $2.00 one one one $5.00 May 18, 2021. 48% $370,000 $925,000 On September 1, 2017, $10,000,000 $20,000,000. may one 10 $500,000. no five no seven 90% five no may not may 75% may, ● sell shares to MSC on the Closing Date using the Purchase Price; or ● provide MSC the opportunity to purchase some or all of the shares using the Minimum Price instead of the Purchase Price. The Company is under no 18 may September 30, 2017, not no Shares Issued to Officer In connection with an employment agreement described in Note 10, 1,200,000 $0.001 $0.75 $898,800 $0.75 $0.001 $37,450 $131,075 September 30, 2017 2016, September 30, 2017, no September 30, 2017, Shares Issued to Consultants On February 19, 2015, 50,000 December 1, 2014 25,000 25,000 six 12 $34,250 $0 $5,708 September 30, 2017 2016, Shares Issued to Lessor As described in Note 10, October 17, 2016, 100,000 $0.0001 3,640,000 $1.00 October 17, 2018 October 17, 2020. not Stock Options Options Issuances in 2016 There were no 2016. Options Issuances in 2017 On August 18, 2017, may 1,500,000 one August 18, 2017, 150,000 four $2.50 August 21, 2021. ● Risk-free interest rate – 1.62 ● Expected term – 4.0 ● Volatility – 179 As these options were fully vested at grant date, the full value of $222,988 no Summary Option Activity The following table shows the stock option activity for the years ended September 30, 2017 2016: Weighted Weighted Average Average Contractual Aggregate Number of Exercise Term Intrinsic Shares Price (Years) Value Outstanding at September 30, 2015 1,205,000 $ 8.70 1.5 $ - Granted - - - - Cancelled - - - - Exercised - - - - Outstanding at September 30, 2016 1,205,000 $ 8.70 1.5 $ - Granted 150,000 $ 2.50 4.0 - Cancelled - - - - Exercised 50,000 $ 0.75 2.0 - Outstanding as of September 30, 2017 1,305,000 $ 8.29 0.9 $ - Vested and expected to vest at September 30, 2017 1,305,000 $ 8.29 0.9 $ - Exercisable at September 30, 2017 1,305,000 $ 8.29 0.9 $ - Stock based compensation expense related to the options was $222,988 $9,173 September 30, 2017 2016, September 30, 2017, no September 30, 2017 2016, $37,500 $0, Warrants Warrant Issuances in 2016 On July 14, 2016, $500,000 6 400,000 800,000 $1.50 800,000 $3.00 June 30, 2020. first $510,960 $1.02 $1.25 4 0.96% 100% 0% second $410,328 $1.02 $3.00 4 0.96% 100% 0% The warrants to purchase the first 800,000 45 $3.00 twenty twenty 100,000 The warrants to purchase the additional 800,000 45 $4.80 twenty twenty 100,000 On September 15, 2016, $25,000 three 75,000 $0.75 75,000 $1.25 September 15, 2020. Warrant Issuances in 2017 During the year ended September 30, 2017, 185,000 $2.00 one one one $5.00 May 18, 2021. 48% $370,000 $925,000 On November 7, 2016, 2,000,000 $1.00 one one one $3.00 November 4, 2020. 43% $2,000,000 $6,000,000 As described in Note 10, October 17, 2016, 100,000 $0.0001 3,640,000 $1.00 October 17, 2018 October 17, 2020. not The following table shows the warrant activity for the years ended September 30, 2017 2016: Weighted Weighted Average Average Contractual Aggregate Number of Exercise Term Intrinsic Shares Price (Years) Value Outstanding at September 30, 2015 2,591,000 $ 8.92 2.7 $ - Granted 1,750,000 2.14 3.8 $ - Cancelled - - - - Exercised - - - - Outstanding at September 30, 2016 4,341,000 $ 6.19 2.1 $ - Granted 5,825,000 1.81 3.1 $ - Cancelled - - - - Exercised - - - - Outstanding as of September 30, 2017 10,166,000 $ 3.68 2.4 $ 3,756,000 Vested and expected to vest at September 30, 2017 10,166,000 $ 3.68 2.4 $ - Exercisable at September 30, 2017 6,526,000 $ 5.18 2.0 $ 480,000

Note 10 - Commitments and Conti

Note 10 - Commitments and Contingencies	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	NOTE 10. Coastal Compassion. April 7, 2016, one Pursuant to the agreements, we agreed to provide CCI with financing of up to $2.5 five 18% three April 1, 2016, $10,000 not As of December 31, 2017, $131,589, $119,635, $11,954. Operating Leases Land On October 17, 2016, 52.6 $925,000 $4,475,000. $3,550,000 47 As part of a simultaneous transaction, the Company assigned the property rights to MMP for a nominal fee and entered a lease agreement pursuant to which MMP agreed to lease the property to the Company for an initial term of fifty 50 four 4 ten 10 The lease payments will be the greater of (a) $30,000 $0.38 1.5% not five 5 Between October 17, 2016 April 17, 2017, April 17, 2017. April 17, 2017, Under the terms of the lease, the Company had six $2.6 first six six October 17, 2017, 16 October 17, 2016 $2.6 100,000 $1.50 October 17, 2022. $171,307 three December 31, 2017, On February 16, 2018, 18 October 17, 2016 $2.6 50,000 $1.50 October 17, 2022. The Company received a credit for the $925,000 fifty 50 $1,542 In connection with the sale of the property to MMP and the lease, the Company and MMP entered into a Share Purchase Agreement pursuant to which the Company issued to MMP 100,000 $0.0001 3,640,000 $1.00 October 17, 2018 October 17, 2020. not ● Risk-free interest rate – 1.12 ● Expected term – 4.0 ● Volatility – 100 The Company allocated $1,899,966 $73,000, The lease expense was $108,625 $98,852 three December 31, 2017 2016. December 31, 2017, $256,122 2018, $341,496 2019 2022, $15,026,024 Office space The Company leases its office space located at 1550 80202 $1,845 Except as described above, the Company has no	NOTE 10. Officer Employment Agreement. March 25, 2014, three 50% $12,000 9. Investment Relations Consulting Agreement. December 1, 2014, $4,000 no September 30, 2017 2016. Consulting Agreement. December 1, 2014, no September 30, 2017 2016. MMCC. January 14, 2015, 52.6 47 may $100,000 Between August 2015 September 2016, October 14, 2016. $4,325,000 $725,000, September 30, 2016, $925,000 October 17, 2016, Operating Leases Land On October 17, 2016, 52.6 $925,000 $4,475,000. $3,550,000 47 As part of a simultaneous transaction, the Company assigned the property rights to MMP for a nominal fee and entered a lease agreement pursuant to which MMP agreed to lease the property to the Company for an initial term of fifty 50 four 4 ten 10 The lease payments will be the greater of (a) $30,000 $0.38 1.5% not five 5 Between October 17, 2016 April 17, 2017, April 17, 2017. April 17, 2017, Under the terms of the lease, the Company had six 6 $2.6 first six 6 six 6 twelve 12 October 17, 2016, October 17, 2017, 16 October 17, 2016 $2.6 100,000 $1.50 October 17, 2017 October 17, 2022. The Company received a credit for the $925,000 fifty 50 $1,542 In connection with the sale of the property to MMP and the lease, the Company and MMP entered into a Share Purchase Agreement pursuant to which the Company issued to MMP 100,000 $0.0001 3,640,000 $1.00 October 17, 2018 October 17, 2020. not ● Risk-free interest rate – 1.12 ● Expected term – 4.0 ● Volatility – 115 The Company allocated $1,972,966 $73,000, $506,765 $0 September 30, 2017 2016, Office space The Company leases its office space located at 3200 $2,920 $3,110. $35,610 $35,145 September 30, 2017 2016, Automobiles The Company leases an automobile under an operating lease commencing October 4, 2014 39 $611 $7,390 $7,483 September 30, 2017 2016, At September 30, 2017, 2018 342,406 2019 341,496 2020 341,496 2021 341,496 2022 341,496 Thereafter 15,026,024 Total 16,734,414

Note 11 - Subsequent Events

Note 11 - Subsequent Events	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017
Notes to Financial Statements
Subsequent Events [Text Block]	NOTE 12. On April 7, 2017, January 18, 2018, $1,045,000 18% April 18, 2015 January 18, 2018 $523,023. $1,568,023, On February 12, 2018, $810,000 8% December 31, 2018. may $1.50 540,000 $1.50 October 17, 2022. As described in Note 10, February 16, 2018, 18 October 17, 2016 $2.6 50,000 $1.50 October 17, 2022.	NOTE 11. Convertible loans On October 5, 2017, $128,000 12% October 5, 2018. April 5, 2018 may 15% 35%. April 5, 2018, may not April 5, 2018, $1.35, 1 65 2 $1.00, $1.35, 1 2 On November 13, 2017, $68,000 12% November 13, 2018. May 13, 2018 may 15% 35%. May 13, 2018, may not May 13, 2018, $1.35, 1 65 2 $1.00, $1.35, 1 2 two fifteen Construction loan On October 30, 2017 $800,000 three first 3 Nov 17, 2017, The loan bears interest at 8% April 30, 2018. $1.50, may 5 The loan is secured by a second 10 ● use all or a portion of the net proceeds from the sale of the Denver property to purchase restricted shares of the Company’s common stock at a price of $1.50 ● have the net proceeds applied to the unpaid accrued interest and principal amount of the Loan. As further consideration for the loan, the Company issued warrants to the Lenders which allow the Lenders to purchase up to 660,000 $1.50 October 13, 2022. Amendment to Lease on property in Freetown, Massachusetts On October 17, 2016, 52.6 As part of a simultaneous transaction, the Company sold the property to Massachusetts Medical Properties, LLC (“MMP”) and the Company and MMP entered into a lease, pursuant to which MMP leased the property to the Company for an initial term of fifty Under the terms of the lease, the Company had until October 16, 2017 first October 17, 2017 16 October 17, 2016 $2.6 first $2.6 16 October 17, 2016, As further consideration for the amendment to the lease, the Company issued a warrant which allows MMP to purchase 100,000 $1.50 October 17, 2022.

Note 1 - Nature of Business and

Note 1 - Nature of Business and Basis of Presentation	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017
Notes to Financial Statements
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]	NOTE 1. AmeriCann, Inc. ("the Company", “we”, “our” or "the Issuer") was organized under the laws of the State of Delaware on June 25, 2010. On January 17, 2014, 93% The Company's business plan is to offer a comprehensive, turnkey package of services that includes consulting, design, construction and financing to approved and licensed marijuana operators throughout the United States. The Company's business plan is based on the anticipated growth of the regulated marijuana market in the United States. The Company's activities are subject to significant risks and uncertainties including failure to secure funding to properly expand its operations. Basis of Presentation The (a) balance sheet as of September 30, 2017, three December 31, 2017 2016, 10 December 4, 2017. not 2017 10 Certain prior period amounts have been reclassified to conform with current period presentation. These reclassifications have no Restricted Cash The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts in the consolidated statements of cash flows: December 31, September 30, 2017 Cash and cash equivalents $ 732,355 $ 1,627 Restricted cash 365,480 - Total cash, cash equivalents, and restricted cash shown in the cash flow statement $ 1,097,835 $ 1,627 Amounts included in restricted cash represent those required to be set aside by a contractual agreement with a lender for the payment of specific construction related expenditures as part of the Company’s property development in Massachusetts. See Notes 5 10. Recent Accounting Pronouncements In July 2017, No. 2017 11, 260 480 815 no December 15, 2018, In May 2017, No. 2017 09, 718 1 2 718, 718. December 15, 2017, not In February 2017, No. 2017 05, 610 20 610 20, 610 20, May 2014 No. 2014 09, 606 December 15, 2017, No. 2014 09, In January 2017, No. 2017 03, 250 No. 2014 09, 606 No. 2016 02, 842 No. 2016 13, 326 not No. 2014 09 Between May 2014 December 2016, 606 five may December 15, 2017, not In November 2016, No. 2016 18, 230 December 15, 2017, first October 1, 2017. no In February 2016, No. 2016 02, 842 2016 02” 2016 02 2016 02, 12 2016 02 December 15, 2018 ( 2016 02	NOTE 1. Description of Business AmeriCann, Inc. ("the Company", “we”, “our”, or "the Issuer") was organized under the laws of the State of Delaware on June 25, 2010. On January 17, 2014, 93% The Company's new business plan is to offer a comprehensive, turnkey package of services that includes consulting, design, construction and financing to approved and licensed marijuana operators throughout the United States. The Company's business plan is based on the anticipated growth of the regulated marijuana market in the United States. The Company's activities are subject to significant risks and uncertainties including failure to secure funding to expand its operations. Certain prior period amounts have been reclassified to conform with current period presentation. These reclassifications have no All significant intercompany balances and transactions have been eliminated in the consolidated financial statements. Summary of Significant Accounting Policies This summary of significant accounting policies of the Company is presented to assist in understanding the Company’s consolidated financial statements. The consolidated financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States and have been consistently applied in the preparation of the consolidated financial statements. Principles of Consolidation The consolidated financial statements include the accounts of AmeriCann, Inc. and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in the consolidated financial statements. Use of Estimates The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The more significant estimates and assumptions made by management are valuation of equity instruments, deferred tax asset valuation and allowance and collectability of long-lived assets. Actual results could differ from those estimates as the current economic environment has increased the degree of uncertainty inherent in these estimates and assumptions. See Note 3 Cash and Cash Equivalents Cash and cash equivalents includes cash on hand, demand deposit accounts and temporary cash investments with maturities of ninety Income Taxes In accordance with ASC Topic 740, not not We expect to recognize the financial statement benefit of an uncertain tax position only after considering the probability that a tax authority would sustain the position in an examination. For tax positions meeting a "more-likely-than- not" not no September 30, 2017, no no not Concentration of Credit Risks and Significant Customers Financial instruments that potentially subject us to concentrations of credit risk consist principally of cash, notes receivables, deposits, accounts receivables and notes receivable. We place our cash with high credit quality financial institutions. As of September 30, 2017, $125,327 $1,250,014 $469,699 3 For the years ended September 30, 2017 2016, one 4900 Financial Instruments and Fair Value of Financial Instruments We adopted ASC Topic 820, 820 ASC Topic 820 820 Level 1: Observable inputs such as quoted market prices in active markets for identical assets or liabilities Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data Level 3: Unobservable inputs for which there is little or no The carrying value of financial assets and liabilities recorded at fair value is measured on a recurring or nonrecurring basis. Financial assets and liabilities measured on a non-recurring basis are those that are adjusted to fair value when a significant event occurs. We had no no Derivative Liabilities We evaluate stock options, stock warrants or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for under the relevant sections of ASC Topic 815 40, 815 40 none September 30, 2017 2016. Long-Lived Assets Our long-lived assets consisted of property, equipment and real estate and are reviewed for impairment in accordance with the guidance of the Topic ASC Topic 360, 205, may not third September 30, 2017, $639,497 no September 30, 2016. Property and Equipment Property and equipment are stated at cost. Depreciation of property and equipment is provided using the straight-line method for financial reporting purposes at rates based on the estimated useful lives of the assets. Estimated useful lives range from three seven 360 45. Construction in progress (CIP) CIP consists of initial costs associated with the construction of our medical cannabis center, including interest expenses. When CIP is finished the asset will be transferred to property and equipment. No Capitalized Interest The Company capitalizes interest to construction in progress made in connection with medical center cannabis construction that are not $28,697 $0 September 30, 2017, 2016, Equity Instruments Issued to Non-Employees for Acquiring Goods or Services Issuances of our common stock or warrants for acquiring goods or services are measured at the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. The measurement date for the fair value of the equity instruments issued to consultants or vendors is determined at the earlier of (i) the date at which a commitment for performance to earn the equity instruments is reached (a "performance commitment" which would include a penalty considered to be of a magnitude that is a sufficiently large disincentive for nonperformance) or (ii) the date at which performance is complete. Although situations may may not Non-Cash Equity Transactions Shares of equity instruments issued for noncash consideration are recorded at the estimated fair market value of the consideration granted based on the estimated fair market value of the equity instrument, or at the estimated fair market value of the goods or services received, whichever is more readily determinable. Stock-Based Compensation We account for share-based awards to employees in accordance with ASC Topic 718, 505 50, Related Parties A party is considered to be related to us if the party directly or indirectly or through one may one one one one Revenue Recognition We recognize revenue when (i) persuasive evidence of an arrangement exists; (ii) the fee is fixed or determinable; (iii) performance of service has been delivered; and (iv) collection is reasonably assured. Advertising Expense Advertising, promotional and selling expenses consisted of sales and marketing expenses, and promotional activity expenses. Expenses are recognized when incurred. General and Administrative Expense General and administrative expenses consisted of professional service fees, rent and utility expenses, meals, travel and entertainment expenses, and other general and administrative overhead costs. Expenses are recognized when incurred. Loss per Share We compute net loss per share in accordance with the ASC Topic 260. Basic loss per share amounts is computed by dividing the net loss by the weighted average number of common shares outstanding. Shares issuable upon the exercise of equity instruments such as warrants and options were not Recently Adopted Accounting Pronouncements In August 2014, No. 2014 15, 205 40 January 1, 2017; not 2 Recently Issued Accounting Pronouncements Between May 2014 December 2016, 606 five may December 15, 2017, not 2018. In February 2016, No. 2016 02, 842 842 not December 15, 2018, may In March 2016, No. 2016 09, 718 1 2 3 December 15, 2016, In August 2016, No. 2016 15, 230 December 15, 2017, In November 2016, No. 2016 18, 230 December 15, 2017, not In January 2017, No. 2017 03, 250 No. 2014 09, 606 No. 2016 02, 842 No. 2016 13, 326 In March 2017, No. 2017 08, 310 20 December 15, 2018. In February 2017, No. 2017 05, 610 20 610 20, 610 20, May 2014 No. 2014 09, 606 December 15, 2017, No. 2014 09, In May 2017, No. 2017 09, 718 1 2 718, 718. December 15, 2017, not In July 2017, No. 2017 11, 260 480 815 no December 15, 2018,

Note 2 - Going Concern24

Note 2 - Going Concern	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017
Notes to Financial Statements
Substantial Doubt about Going Concern [Text Block]	NOTE 2. The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates, among other things, the realization of assets and satisfaction of liabilities in the normal course of business. The Company had an accumulated deficit of $10,051,189 $8,676,825 December 31, 2017 September 30, 2017, $1,374,364 three December 31, 2017. $1,251,829 $469,699 may not may not April 7, 2017. no not January 18, 2018, $1,045,000 18% April 18, 2015 January 18, 2018 $523,023. $1,568,023, not Management believes that the actions presently being taken to further implement its business plan and generate additional revenues provide the opportunity for the Company to continue as a going concern. While the Company believes in the viability of its strategy to generate additional revenues and in its ability to raise additional funds, there can be no not	NOTE 2. The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates, among other things, the realization of assets and satisfaction of liabilities in the normal course of business. The Company had an accumulated deficit of $8,676,825 $5,904,931 September 30, 2017 2016, $2,771,894 September 30, 2017 $1,735,989. $1,250,014 $469,699 may not may not April 7, 2017. January 8, 2018. To date, the Company has funded its operations primarily by way of the sale of equity securities, convertible note financing, short term financing from private parties, and advances from related parties. The Company currently needs to raise additional capital in order to fund operations, maintain the land lease agreement, as well as to make payments on existing liabilities. The Company is continuing to raise capital, as it did during the year ended September 30, 2017, $7 twelve September 1, 2017, $10,000,000 $20,000,000. October 5, 2017, $1,760,000. October 30, 2017 $800,000 three no may not

Note 3 - Notes and Other Receiv

Note 3 - Notes and Other Receivables	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017
Notes to Financial Statements
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]	NOTE 3. Notes and other receivables as of December 31, 2017 September 30, 2017, December 31, September 30, 2017 Notes and other receivables from WGP, a licensed medical marijuana cultivator; $673,294 note secured by real and personal property of the borrower, interest rate of 18.0%; accrued consulting fees of $40,000, construction advances of $332,357 and accrued interest of $206,178. Net of reserves of $469,699. All amounts are due and payable immediately. 782,130 780,315 Related party note receivable from CCI, a non-profit corporation, financing of up to $2.5 million through April 2021, interest rate of 18.0%; monthly principal and interest payments commencing the sixth month after CCI begins to generate sales; construction and working capital advances of $119,635, and accrued interest of $11,954; unsecured. 131,589 125,327 $ 913,719 $ 905,642 The notes and other receivables from WGP are classified as long term due to ongoing disputes between the Company and WGP. The Company recently won an arbitration hearing against WGP, but will not	NOTE 3. Notes and Other Receivables consisted of the following: September 30, September 30, 2016 Note receivable from 4900 Jackson, LLC, a licensed dispensary, interest rate of 12.0%; monthly principal and interest payments of $50,000, with a balloon payment of $182,531 due on May 1, 2017; collateralized by the borrower's assets. $ - $ 247,378 Notes and other receivables from WGP, a licensed medical marijuana cultivator; $673,294 note secured by real and personal property of the borrower, interest rate of 18.0%; accrued consulting fees of $40,000, construction advances of $332,357 and accrued interest of $204,363. Net of reserves of $469,699. All amounts are due and payable immediately. 780,315 780,315 Related party note receivable from CCI, a non-profit corporation, financing of up to $2.5 million through April 2021, interest rate of 18.0%; monthly principal and interest payments commencing the sixth month after CCI begins to generate sales; construction and working capital advances of $119,635, and accrued interest of $5,692; unsecured. 125,327 57,693 905,642 1,085,386 Less: Current portion - 247,378 $ 905,642 $ 838,008 The notes and other receivables from WGP are classified as long term due to ongoing disputes between the Company and WGP. We filed a Demand for Arbitration against WGP on April 7, 2017. January 8, 2018.

Note 4 - Land

Note 4 - Land	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017
Land [Member]
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	NOTE 4. On July 31, 2014, five 4200 $2,250,809. October 5, 2017, $1,760,000 third September 30, 2017 $1,611,312, September 30, 2017 $1,611,312. The land sale was completed on December 4, 2017 $2,861 December 31, 2017 $990,000 $17,088 $601,363 $800,000 second	NOTE 4. On July 31, 2014, five $2,250,000. $990,000 March 15, 2018. 5 October 5, 2017, $1,760,000 $639,497 September 30, 2017 $1,611,312, September 30, 2017 $1,611,312.

Note 5 - Notes Payable27

Note 5 - Notes Payable	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017
Notes to Financial Statements
Debt Disclosure [Text Block]	NOTE 5. Unrelated The Company maintained a loan secured by a first five December 31, 2017, $990,000 4. On August 25, 2017, $150,000. 12% May 31, 2018. December 31, 2017, $89,677 $4,311. $3,057 $0 three December 31, 2017 2016, Convertible loans On October 5, 2017, $128,000 12% October 5, 2018. April 5, 2018 may 15% 35%. April 5, 2018, may not April 5, 2018, $1.35, 1 65 2 $1.00, $1.35, 1 2 two fifteen $3,000 December 31, 2017. not no December 31, 2017. $750 $0 three December 31, 2017 2016, On November 13, 2017, $68,000 12% November 13, 2018. May 13, 2018 may 15% 35%. May 13, 2018, may not May 13, 2018, $1.35, 1 65 2 $1.00, $1.35, 1 2 two fifteen $3,000 December 31, 2017. not no December 31, 2017. $500 $0 three December 31, 2017 2016, Construction loan On October 30, 2017 $800,000 three first 3 Nov 17, 2017, The loan bears interest at 8% April 30, 2018. $1.50, may 5 As further consideration for the loan, the Company issued warrants to the Lenders which allow the Lenders to purchase up to 660,000 $1.50 October 30, 2022. 660,000 $442,388 $357,612 As described in Note 4, December 4, 2017, $601,363 not $712,736 $0 three December 31, 2017 2016, Convertible Note Offering On December 29, 2017 $800,000 8% December 31, 2018. may $1.50 The note holders also received warrants which entitle the note holders to purchase up to 533,333 $1.50 October 17, 2022. GVC Capital LLC acted as the placement agent for the offering and received a cash commission of $64,000, 106,667 $1.50 December 29, 2022. The Company allocated the proceeds between the note and the warrants based on their relative fair values. The relative fair value of the 640,000 $607,024 $128,976 In connection with the offering, the Company paid fees of $64,000 $48,562 $15,438, All debt discounts are being recognized on a straight-line basis over the terms of the notes. As the transaction occurred just prior to the quarter end, no December 31, 2017. Related Party On February 1, 2016, $200,000. May 1, 2016, $1,000,000. July 14, 2016, $521,297 $2,431,646. one On July 14, 2016, two Of the amounts owed to SCP, $500,000 400,000 $1.25 The remaining $1,931,646 two The first $1,000,000, 9.5% December 31, 2019. $1.25 not If the average closing price of our common stock is at least $2.50 twenty twenty 100,000 may, 10 twenty 45 The second $931,646, 8% December 31, 2019. not first December 31, 2019. Accrued interest on these notes payable was $106,596 $84,998 December 31, 2017 2016, In connection with the debt modification agreement, we issued SCP warrants to purchase 800,000 $1.50 800,000 $3.00 June 30, 2020. $72,651 December 31, 2017, $1,931,646, $41,696. $5,341 $9,763 three December 30, 2017 2016.	NOTE 5. Unrelated On September 15, 2015, $900,000. 12% March 16, 2016. $650,000 April 6, 2016, $990,000, 18% March 15, 2017. 470 50, $90,000 September 30, 2016. March 15, 2017, March 15, 2018, 18% may $188,100 $150,497 September 30, 2017 2016, As of September 30, 2016, $203,247 8% 18%, December 14, 2016, January 15, 2017, $75,000 $0.75. 75,000 $0.75 75,000 $1.25 September 15, 2020. $35,250 $35,250 September 30, 2017, $24,657 $227,904. September 30, 2017, $0. September 30, 2017, no no $4,267 $12,337 September 30, 2017 2016, On August 25, 2017, $150,000. 12% May 31, 2018. September 30, 2017, $80,000. September 30, 2017, $1,255. $1,255 $0 September 30, 2017 2016, Related Party On February 1, 2016, $200,000. May 1, 2016, $1,000,000. July 14, 2016, $521,297 $2,431,646. one On July 14, 2016, two Of the amounts owed to SCP, $500,000 400,000 $1.25 The remaining $1,931,646 two The first $1,000,000, 9.5% December 31, 2019. $1.25 not September 30, 2017, $47,630. If the average closing price of our common stock is at least $2.50 twenty twenty 100,000 may, 10 twenty 45 The second $931,646, 8% December 31, 2019. not second first December 31, 2019. September 30, 2017, $37,368. The Company analyzed the modification of the note under ASC Topic 470, $901,939 September 30, 2016. In connection with the debt modification agreement, we issued SCP warrants to purchase 800,000 $1.50 800,000 $3.00 June 30, 2020. 9 $72,651 At September 30, 2017, $1,978,683, $47,037. $25,614 $0 September 30, 2017 2016,

Note 6 - Related Party Transa28

Note 6 - Related Party Transactions	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	NOTE 6. Strategic Capital Partners. December 31, 2017 September 30, 2017, $1,931,646 $1,978,683, Interest expense was $37,390 $32,968 three December 31, 2017 2016, $106,596 $84,998 December 31, 2017 September 30, 2017, $21,133 December 31, 2017. Coastal Compassion. April 7, 2016, one Pursuant to the agreements, we agreed to provide CCI with financing of up to $2.5 five 18% three April 1, 2016, $10,000 not As of December 31, 2017, $131,589, $119,635, $11,954.	NOTE 6. Strategic Capital Partners. September 30, 2017 2016, $1,978,683 $2,024,297, July 14, 2016, $500,000 400,000 $1,931,646 two 5 9. Interest expense was $143,917 $109,825 September 30, 2017 2016, $84,998 $109,825 September 30, 2017 September 30, 2016, 2017, $194,358, $20,000, no 2016, $247,500 no Coastal Compassion. April 7, 2016, one Pursuant to the agreements, we agreed to provide CCI with financing of up to $2.5 five 18% three April 1, 2016, $10,000 not six not As of September 30, 2017, $125,327, $119,635, $5,692.

Note 7 - Loss Per Share

Note 7 - Loss Per Share	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017
Notes to Financial Statements
Earnings Per Share [Text Block]	NOTE 7. The following table sets forth the computation of basic and diluted net loss per share: Three Months Ended December 31, 2017 2016 Net loss attributable to common stockholders $ (1,374,364 ) $ (516,765 ) Basic weighted average outstanding shares of common stock 19,366,000 18,236,435 Dilutive effects of common share equivalents - - Dilutive weighted average outstanding shares of common stock 19,366,000 18,236,435 Basic and diluted net loss per share of common stock $ (0.07 ) $ (0.03 ) As of December 31, 2017, 1,305,000 11,566,000 December 31, 2016, 1,205,000 9,981,000	NOTE 7. The following table sets forth the computation of basic and diluted net loss per share: Year Ended September 30, 2017 2016 Net loss attributable to common stockholders $ (2,771,894 ) $ (2,210,764 ) Basic weighted average outstanding shares of common stock 19,007,371 17,031,000 Dilutive effects of common share equivalents - - Dilutive weighted average outstanding shares of common stock 19,007,371 17,031,000 Basic and diluted net loss per share of common stock $ (0.15 ) $ (0.13 ) As of September 30, 2017, 1,305,000 10,166,000 September 30, 2016, 1,205,000 4,341,000

Note 8 - Income Taxes30

Note 8 - Income Taxes	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017
Notes to Financial Statements
Income Tax Disclosure [Text Block]	NOTE 8. We did not three December 31, 2017. not December 31, 2017. As of December 31, 2017, not no September 30, 2017.	NOTE 8. Deferred income taxes arise from the temporary differences between financial statement and income tax recognition of net operating losses. These loss carryovers are limited under the Internal Revenue Code should a significant change in ownership occur. The Company accounts for income taxes pursuant to ASC Topic 740. 2015 17, September 30, 2016. Deferred income taxes arise from the temporary differences between financial statement and income tax recognition of net operating losses and other items. Loss carryovers are limited under the Internal Revenue Code should a significant change in ownership occur. The components of the deferred income tax assets and liabilities arising under ASC Topic 740 September 30, 2017 2016 Deferred tax assets $ - $ - Deferred tax liabilities - - Net deferred tax assets/(liabilities) $ - $ - The types of temporary differences between the tax basis of assets and their financial reporting amounts that give rise to a significant portion of the deferred assets and liabilities are as follows: September 30, 2017 2016 Temporary Difference Tax Effect Temporary Difference Tax Effect Deferred tax assets Net operating loss $ 1,789,958 $ 663,358 $ 1,156,331 $ 428,536 Other temporary differences 716,750 265,628 9,261 3,432 Net deferred tax assets 2,506,708 928,986 1,165,592 431,968 Valuation allowance (2,506,708 ) (928,986 ) (1,165,592 ) (431,968 ) Total deferred tax asset - - - - Deferred tax liabilities Total deferred liability - - - - Total net deferred tax asset $ - $ - $ - $ - At September 30, 2017 September 30, 2016, $4,370,404 $2,551,748 2034. $928,986 $431,968 100% September 30, 2017 September 30, 2016 $497,018 $27,396. A reconciliation of the U.S. statutory federal income tax rate to the effective tax rate is as follows: September 30, 2017 2016 U.S. Federal statutory graduated rate 34.00 % 34.00 % State income tax rate, net of federal benefit 3.06 % 3.06 % Total rate 37.06 % 37.06 % Less: Net operating loss for which no benefit is currently available (37.06 )% (37.06 )% Net effective rate 0.00 % 0.00 % The Company’s income tax filings are subject to audit by various taxing authorities. The Company’s open audit periods are September 30, 2015, 2016, 2017.

Note 9 - Stock Based Compensati

Note 9 - Stock Based Compensation	3 Months Ended
	Dec. 31, 2017
Notes to Financial Statements
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	NOTE 9. Restricted Stock Awards. December 31, 2017, no $0 $18,725 three December 31, 2017 2016, December 31, 2017, no Stock Options . no December 31, 2017. Weighted Weighted Average Average Contractual Aggregate Number of Exercise Term Intrinsic Shares Price (Years) Value Outstanding and exercisable at December 31, 2017 1,305,000 $ 8.29 0.6 $ 431,200 There was no three December 31, 2017 2016. December 31, 2017, no

Note 10 - Commitments and Con32

Note 10 - Commitments and Contingencies	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	NOTE 10. Coastal Compassion. April 7, 2016, one Pursuant to the agreements, we agreed to provide CCI with financing of up to $2.5 five 18% three April 1, 2016, $10,000 not As of December 31, 2017, $131,589, $119,635, $11,954. Operating Leases Land On October 17, 2016, 52.6 $925,000 $4,475,000. $3,550,000 47 As part of a simultaneous transaction, the Company assigned the property rights to MMP for a nominal fee and entered a lease agreement pursuant to which MMP agreed to lease the property to the Company for an initial term of fifty 50 four 4 ten 10 The lease payments will be the greater of (a) $30,000 $0.38 1.5% not five 5 Between October 17, 2016 April 17, 2017, April 17, 2017. April 17, 2017, Under the terms of the lease, the Company had six $2.6 first six six October 17, 2017, 16 October 17, 2016 $2.6 100,000 $1.50 October 17, 2022. $171,307 three December 31, 2017, On February 16, 2018, 18 October 17, 2016 $2.6 50,000 $1.50 October 17, 2022. The Company received a credit for the $925,000 fifty 50 $1,542 In connection with the sale of the property to MMP and the lease, the Company and MMP entered into a Share Purchase Agreement pursuant to which the Company issued to MMP 100,000 $0.0001 3,640,000 $1.00 October 17, 2018 October 17, 2020. not ● Risk-free interest rate – 1.12 ● Expected term – 4.0 ● Volatility – 100 The Company allocated $1,899,966 $73,000, The lease expense was $108,625 $98,852 three December 31, 2017 2016. December 31, 2017, $256,122 2018, $341,496 2019 2022, $15,026,024 Office space The Company leases its office space located at 1550 80202 $1,845 Except as described above, the Company has no	NOTE 10. Officer Employment Agreement. March 25, 2014, three 50% $12,000 9. Investment Relations Consulting Agreement. December 1, 2014, $4,000 no September 30, 2017 2016. Consulting Agreement. December 1, 2014, no September 30, 2017 2016. MMCC. January 14, 2015, 52.6 47 may $100,000 Between August 2015 September 2016, October 14, 2016. $4,325,000 $725,000, September 30, 2016, $925,000 October 17, 2016, Operating Leases Land On October 17, 2016, 52.6 $925,000 $4,475,000. $3,550,000 47 As part of a simultaneous transaction, the Company assigned the property rights to MMP for a nominal fee and entered a lease agreement pursuant to which MMP agreed to lease the property to the Company for an initial term of fifty 50 four 4 ten 10 The lease payments will be the greater of (a) $30,000 $0.38 1.5% not five 5 Between October 17, 2016 April 17, 2017, April 17, 2017. April 17, 2017, Under the terms of the lease, the Company had six 6 $2.6 first six 6 six 6 twelve 12 October 17, 2016, October 17, 2017, 16 October 17, 2016 $2.6 100,000 $1.50 October 17, 2017 October 17, 2022. The Company received a credit for the $925,000 fifty 50 $1,542 In connection with the sale of the property to MMP and the lease, the Company and MMP entered into a Share Purchase Agreement pursuant to which the Company issued to MMP 100,000 $0.0001 3,640,000 $1.00 October 17, 2018 October 17, 2020. not ● Risk-free interest rate – 1.12 ● Expected term – 4.0 ● Volatility – 115 The Company allocated $1,972,966 $73,000, $506,765 $0 September 30, 2017 2016, Office space The Company leases its office space located at 3200 $2,920 $3,110. $35,610 $35,145 September 30, 2017 2016, Automobiles The Company leases an automobile under an operating lease commencing October 4, 2014 39 $611 $7,390 $7,483 September 30, 2017 2016, At September 30, 2017, 2018 342,406 2019 341,496 2020 341,496 2021 341,496 2022 341,496 Thereafter 15,026,024 Total 16,734,414

Note 11 - Shareholders' Equity

Note 11 - Shareholders' Equity	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	NOTE 11. Equity Line Agreement. December 12, 2017, $10,000,000 During the term of the Agreement, the Company, at its sole discretion, may one 10 $500,000. A closing will occur on the date which is no five no seven The amount to be paid by MSC on a particular Closing Date will be determined by dividing the dollar amount specified in the Put Notice by the Purchase Price. The Purchase Price is 90% five no may not The Company may 75% may, not $1.00 The Company is under no The equity line agreement has a term of 18 may December 31, 2017, not Warrants. three December 31, 2017 Weighted Weighted Average Average Contractual Aggregate Number of Exercise Term Intrinsic Shares Price (Years) Value Outstanding and exercisable at September 30, 2017 10,166,000 $ 3.68 2.4 $ - Granted 1,400,000 $ 1.50 4.8 Cancelled - Exercised - Outstanding as of December 31, 2017 11,566,000 $ 3.42 2.4 $ 20,461,100 Vested and expected to vest at December 31, 2017 11,566,000 $ 3.42 2.4 $ 20,461,100 Exercisable at December 31, 2017 7,826,000 $ 5.50 2.2 $ 8,954,500 As disclosed in Notes 5 10, 1,400,000 $1.50 ● Expected term – 3 5 ● Volatility – 163% 176% ● Risk-free rate – 1.73% 2.00% ● Stock price - $1.74 $4.09 ● Expected dividends – $0 For those warrants that were issued with debt, the proceeds were allocated to the respective instruments on a pro rata basis based on the fair value of each instrument. See Note 5.	NOTE 9. Preferred Stock The Company has authorized 20,000,000 $.0001 No September 30, 2017 2016. Common Stock On July 14, 2016, $500,000 400,000 $1.25 5. On November 7, 2016, 2,000,000 $1.00 one one one $3.00 November 4, 2020. 43% $2,000,000 $6,000,000 $193,726 On March 21, 2017, 50,000 50,000 $37,500. During the year ended September 30, 2017, 185,000 $2.00 one one one $5.00 May 18, 2021. 48% $370,000 $925,000 On September 1, 2017, $10,000,000 $20,000,000. may one 10 $500,000. no five no seven 90% five no may not may 75% may, ● sell shares to MSC on the Closing Date using the Purchase Price; or ● provide MSC the opportunity to purchase some or all of the shares using the Minimum Price instead of the Purchase Price. The Company is under no 18 may September 30, 2017, not no Shares Issued to Officer In connection with an employment agreement described in Note 10, 1,200,000 $0.001 $0.75 $898,800 $0.75 $0.001 $37,450 $131,075 September 30, 2017 2016, September 30, 2017, no September 30, 2017, Shares Issued to Consultants On February 19, 2015, 50,000 December 1, 2014 25,000 25,000 six 12 $34,250 $0 $5,708 September 30, 2017 2016, Shares Issued to Lessor As described in Note 10, October 17, 2016, 100,000 $0.0001 3,640,000 $1.00 October 17, 2018 October 17, 2020. not Stock Options Options Issuances in 2016 There were no 2016. Options Issuances in 2017 On August 18, 2017, may 1,500,000 one August 18, 2017, 150,000 four $2.50 August 21, 2021. ● Risk-free interest rate – 1.62 ● Expected term – 4.0 ● Volatility – 179 As these options were fully vested at grant date, the full value of $222,988 no Summary Option Activity The following table shows the stock option activity for the years ended September 30, 2017 2016: Weighted Weighted Average Average Contractual Aggregate Number of Exercise Term Intrinsic Shares Price (Years) Value Outstanding at September 30, 2015 1,205,000 $ 8.70 1.5 $ - Granted - - - - Cancelled - - - - Exercised - - - - Outstanding at September 30, 2016 1,205,000 $ 8.70 1.5 $ - Granted 150,000 $ 2.50 4.0 - Cancelled - - - - Exercised 50,000 $ 0.75 2.0 - Outstanding as of September 30, 2017 1,305,000 $ 8.29 0.9 $ - Vested and expected to vest at September 30, 2017 1,305,000 $ 8.29 0.9 $ - Exercisable at September 30, 2017 1,305,000 $ 8.29 0.9 $ - Stock based compensation expense related to the options was $222,988 $9,173 September 30, 2017 2016, September 30, 2017, no September 30, 2017 2016, $37,500 $0, Warrants Warrant Issuances in 2016 On July 14, 2016, $500,000 6 400,000 800,000 $1.50 800,000 $3.00 June 30, 2020. first $510,960 $1.02 $1.25 4 0.96% 100% 0% second $410,328 $1.02 $3.00 4 0.96% 100% 0% The warrants to purchase the first 800,000 45 $3.00 twenty twenty 100,000 The warrants to purchase the additional 800,000 45 $4.80 twenty twenty 100,000 On September 15, 2016, $25,000 three 75,000 $0.75 75,000 $1.25 September 15, 2020. Warrant Issuances in 2017 During the year ended September 30, 2017, 185,000 $2.00 one one one $5.00 May 18, 2021. 48% $370,000 $925,000 On November 7, 2016, 2,000,000 $1.00 one one one $3.00 November 4, 2020. 43% $2,000,000 $6,000,000 As described in Note 10, October 17, 2016, 100,000 $0.0001 3,640,000 $1.00 October 17, 2018 October 17, 2020. not The following table shows the warrant activity for the years ended September 30, 2017 2016: Weighted Weighted Average Average Contractual Aggregate Number of Exercise Term Intrinsic Shares Price (Years) Value Outstanding at September 30, 2015 2,591,000 $ 8.92 2.7 $ - Granted 1,750,000 2.14 3.8 $ - Cancelled - - - - Exercised - - - - Outstanding at September 30, 2016 4,341,000 $ 6.19 2.1 $ - Granted 5,825,000 1.81 3.1 $ - Cancelled - - - - Exercised - - - - Outstanding as of September 30, 2017 10,166,000 $ 3.68 2.4 $ 3,756,000 Vested and expected to vest at September 30, 2017 10,166,000 $ 3.68 2.4 $ - Exercisable at September 30, 2017 6,526,000 $ 5.18 2.0 $ 480,000

Note 12 - Subsequent Events

Note 12 - Subsequent Events	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017
Notes to Financial Statements
Subsequent Events [Text Block]	NOTE 12. On April 7, 2017, January 18, 2018, $1,045,000 18% April 18, 2015 January 18, 2018 $523,023. $1,568,023, On February 12, 2018, $810,000 8% December 31, 2018. may $1.50 540,000 $1.50 October 17, 2022. As described in Note 10, February 16, 2018, 18 October 17, 2016 $2.6 50,000 $1.50 October 17, 2022.	NOTE 11. Convertible loans On October 5, 2017, $128,000 12% October 5, 2018. April 5, 2018 may 15% 35%. April 5, 2018, may not April 5, 2018, $1.35, 1 65 2 $1.00, $1.35, 1 2 On November 13, 2017, $68,000 12% November 13, 2018. May 13, 2018 may 15% 35%. May 13, 2018, may not May 13, 2018, $1.35, 1 65 2 $1.00, $1.35, 1 2 two fifteen Construction loan On October 30, 2017 $800,000 three first 3 Nov 17, 2017, The loan bears interest at 8% April 30, 2018. $1.50, may 5 The loan is secured by a second 10 ● use all or a portion of the net proceeds from the sale of the Denver property to purchase restricted shares of the Company’s common stock at a price of $1.50 ● have the net proceeds applied to the unpaid accrued interest and principal amount of the Loan. As further consideration for the loan, the Company issued warrants to the Lenders which allow the Lenders to purchase up to 660,000 $1.50 October 13, 2022. Amendment to Lease on property in Freetown, Massachusetts On October 17, 2016, 52.6 As part of a simultaneous transaction, the Company sold the property to Massachusetts Medical Properties, LLC (“MMP”) and the Company and MMP entered into a lease, pursuant to which MMP leased the property to the Company for an initial term of fifty Under the terms of the lease, the Company had until October 16, 2017 first October 17, 2017 16 October 17, 2016 $2.6 first $2.6 16 October 17, 2016, As further consideration for the amendment to the lease, the Company issued a warrant which allows MMP to purchase 100,000 $1.50 October 17, 2022.

Significant Accounting Policies

Significant Accounting Policies (Policies)	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017
Accounting Policies [Abstract]
Use of Estimates, Policy [Policy Text Block]		Use of Estimates The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The more significant estimates and assumptions made by management are valuation of equity instruments, deferred tax asset valuation and allowance and collectability of long-lived assets. Actual results could differ from those estimates as the current economic environment has increased the degree of uncertainty inherent in these estimates and assumptions. See Note 3
Cash and Cash Equivalents, Policy [Policy Text Block]		Cash and Cash Equivalents Cash and cash equivalents includes cash on hand, demand deposit accounts and temporary cash investments with maturities of ninety
Income Tax, Policy [Policy Text Block]		Income Taxes In accordance with ASC Topic 740, not not We expect to recognize the financial statement benefit of an uncertain tax position only after considering the probability that a tax authority would sustain the position in an examination. For tax positions meeting a "more-likely-than- not" not no September 30, 2017, no no not
Concentration Risk, Credit Risk, Policy [Policy Text Block]		Concentration of Credit Risks and Significant Customers Financial instruments that potentially subject us to concentrations of credit risk consist principally of cash, notes receivables, deposits, accounts receivables and notes receivable. We place our cash with high credit quality financial institutions. As of September 30, 2017, $125,327 $1,250,014 $469,699 3 For the years ended September 30, 2017 2016, one 4900
Fair Value of Financial Instruments, Policy [Policy Text Block]		Financial Instruments and Fair Value of Financial Instruments We adopted ASC Topic 820, 820 ASC Topic 820 820 Level 1: Observable inputs such as quoted market prices in active markets for identical assets or liabilities Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data Level 3: Unobservable inputs for which there is little or no The carrying value of financial assets and liabilities recorded at fair value is measured on a recurring or nonrecurring basis. Financial assets and liabilities measured on a non-recurring basis are those that are adjusted to fair value when a significant event occurs. We had no no
Derivatives, Policy [Policy Text Block]		Derivative Liabilities We evaluate stock options, stock warrants or other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for under the relevant sections of ASC Topic 815 40, 815 40 none September 30, 2017 2016.
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]		Long-Lived Assets Our long-lived assets consisted of property, equipment and real estate and are reviewed for impairment in accordance with the guidance of the Topic ASC Topic 360, 205, may not third September 30, 2017, $639,497 no September 30, 2016.
Property, Plant and Equipment, Policy [Policy Text Block]		Property and Equipment Property and equipment are stated at cost. Depreciation of property and equipment is provided using the straight-line method for financial reporting purposes at rates based on the estimated useful lives of the assets. Estimated useful lives range from three seven 360 45.
Property, Plant and Equipment, Construction in Progress, Policy [Policy Text Block]		Construction in progress (CIP) CIP consists of initial costs associated with the construction of our medical cannabis center, including interest expenses. When CIP is finished the asset will be transferred to property and equipment. No
Interest Capitalization, Policy [Policy Text Block]		Capitalized Interest The Company capitalizes interest to construction in progress made in connection with medical center cannabis construction that are not $28,697 $0 September 30, 2017, 2016,
Commissions Expense, Policy [Policy Text Block]		Equity Instruments Issued to Non-Employees for Acquiring Goods or Services Issuances of our common stock or warrants for acquiring goods or services are measured at the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. The measurement date for the fair value of the equity instruments issued to consultants or vendors is determined at the earlier of (i) the date at which a commitment for performance to earn the equity instruments is reached (a "performance commitment" which would include a penalty considered to be of a magnitude that is a sufficiently large disincentive for nonperformance) or (ii) the date at which performance is complete. Although situations may may not
Business Combinations and Other Purchase of Business Transactions, Policy [Policy Text Block]		Non-Cash Equity Transactions Shares of equity instruments issued for noncash consideration are recorded at the estimated fair market value of the consideration granted based on the estimated fair market value of the equity instrument, or at the estimated fair market value of the goods or services received, whichever is more readily determinable.
Compensation Related Costs, Policy [Policy Text Block]		Stock-Based Compensation We account for share-based awards to employees in accordance with ASC Topic 718, 505 50,
Collaborative Arrangement, Accounting Policy [Policy Text Block]		Related Parties A party is considered to be related to us if the party directly or indirectly or through one may one one one one
Revenue Recognition, Policy [Policy Text Block]		Revenue Recognition We recognize revenue when (i) persuasive evidence of an arrangement exists; (ii) the fee is fixed or determinable; (iii) performance of service has been delivered; and (iv) collection is reasonably assured.
Advertising Costs, Policy [Policy Text Block]		Advertising Expense Advertising, promotional and selling expenses consisted of sales and marketing expenses, and promotional activity expenses. Expenses are recognized when incurred.
Selling, General and Administrative Expenses, Policy [Policy Text Block]		General and Administrative Expense General and administrative expenses consisted of professional service fees, rent and utility expenses, meals, travel and entertainment expenses, and other general and administrative overhead costs. Expenses are recognized when incurred.
Earnings Per Share, Policy [Policy Text Block]		Loss per Share We compute net loss per share in accordance with the ASC Topic 260. Basic loss per share amounts is computed by dividing the net loss by the weighted average number of common shares outstanding. Shares issuable upon the exercise of equity instruments such as warrants and options were not
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Pronouncements In July 2017, No. 2017 11, 260 480 815 no December 15, 2018, In May 2017, No. 2017 09, 718 1 2 718, 718. December 15, 2017, not In February 2017, No. 2017 05, 610 20 610 20, 610 20, May 2014 No. 2014 09, 606 December 15, 2017, No. 2014 09, In January 2017, No. 2017 03, 250 No. 2014 09, 606 No. 2016 02, 842 No. 2016 13, 326 not No. 2014 09 Between May 2014 December 2016, 606 five may December 15, 2017, not In November 2016, No. 2016 18, 230 December 15, 2017, first October 1, 2017. no In February 2016, No. 2016 02, 842 2016 02” 2016 02 2016 02, 12 2016 02 December 15, 2018 ( 2016 02	Recently Adopted Accounting Pronouncements In August 2014, No. 2014 15, 205 40 January 1, 2017; not 2 Recently Issued Accounting Pronouncements Between May 2014 December 2016, 606 five may December 15, 2017, not 2018. In February 2016, No. 2016 02, 842 842 not December 15, 2018, may In March 2016, No. 2016 09, 718 1 2 3 December 15, 2016, In August 2016, No. 2016 15, 230 December 15, 2017, In November 2016, No. 2016 18, 230 December 15, 2017, not In January 2017, No. 2017 03, 250 No. 2014 09, 606 No. 2016 02, 842 No. 2016 13, 326 In March 2017, No. 2017 08, 310 20 December 15, 2018. In February 2017, No. 2017 05, 610 20 610 20, 610 20, May 2014 No. 2014 09, 606 December 15, 2017, No. 2014 09, In May 2017, No. 2017 09, 718 1 2 718, 718. December 15, 2017, not In July 2017, No. 2017 11, 260 480 815 no December 15, 2018,
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation The (a) balance sheet as of September 30, 2017, three December 31, 2017 2016, 10 December 4, 2017. not 2017 10 Certain prior period amounts have been reclassified to conform with current period presentation. These reclassifications have no
Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]	Restricted Cash The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts in the consolidated statements of cash flows: December 31, September 30, 2017 Cash and cash equivalents $ 732,355 $ 1,627 Restricted cash 365,480 - Total cash, cash equivalents, and restricted cash shown in the cash flow statement $ 1,097,835 $ 1,627 Amounts included in restricted cash represent those required to be set aside by a contractual agreement with a lender for the payment of specific construction related expenditures as part of the Company’s property development in Massachusetts. See Notes 5 10.

Note 3 - Notes Receivables (Tab

Note 3 - Notes Receivables (Tables)	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017
Notes Tables
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]	December 31, September 30, 2017 Notes and other receivables from WGP, a licensed medical marijuana cultivator; $673,294 note secured by real and personal property of the borrower, interest rate of 18.0%; accrued consulting fees of $40,000, construction advances of $332,357 and accrued interest of $206,178. Net of reserves of $469,699. All amounts are due and payable immediately. 782,130 780,315 Related party note receivable from CCI, a non-profit corporation, financing of up to $2.5 million through April 2021, interest rate of 18.0%; monthly principal and interest payments commencing the sixth month after CCI begins to generate sales; construction and working capital advances of $119,635, and accrued interest of $11,954; unsecured. 131,589 125,327 $ 913,719 $ 905,642	September 30, September 30, 2016 Note receivable from 4900 Jackson, LLC, a licensed dispensary, interest rate of 12.0%; monthly principal and interest payments of $50,000, with a balloon payment of $182,531 due on May 1, 2017; collateralized by the borrower's assets. $ - $ 247,378 Notes and other receivables from WGP, a licensed medical marijuana cultivator; $673,294 note secured by real and personal property of the borrower, interest rate of 18.0%; accrued consulting fees of $40,000, construction advances of $332,357 and accrued interest of $204,363. Net of reserves of $469,699. All amounts are due and payable immediately. 780,315 780,315 Related party note receivable from CCI, a non-profit corporation, financing of up to $2.5 million through April 2021, interest rate of 18.0%; monthly principal and interest payments commencing the sixth month after CCI begins to generate sales; construction and working capital advances of $119,635, and accrued interest of $5,692; unsecured. 125,327 57,693 905,642 1,085,386 Less: Current portion - 247,378 $ 905,642 $ 838,008

Note 7 - Earnings Per Share (Ta

Note 7 - Earnings Per Share (Tables)	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended December 31, 2017 2016 Net loss attributable to common stockholders $ (1,374,364 ) $ (516,765 ) Basic weighted average outstanding shares of common stock 19,366,000 18,236,435 Dilutive effects of common share equivalents - - Dilutive weighted average outstanding shares of common stock 19,366,000 18,236,435 Basic and diluted net loss per share of common stock $ (0.07 ) $ (0.03 )	Year Ended September 30, 2017 2016 Net loss attributable to common stockholders $ (2,771,894 ) $ (2,210,764 ) Basic weighted average outstanding shares of common stock 19,007,371 17,031,000 Dilutive effects of common share equivalents - - Dilutive weighted average outstanding shares of common stock 19,007,371 17,031,000 Basic and diluted net loss per share of common stock $ (0.15 ) $ (0.13 )

Note 8 - Income Taxes (Tables)

Note 8 - Income Taxes (Tables)	12 Months Ended
	Sep. 30, 2017
Notes Tables
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	September 30, 2017 2016 Deferred tax assets $ - $ - Deferred tax liabilities - - Net deferred tax assets/(liabilities) $ - $ -
Schedule of Temporary Differences of Deferred Tax Assets and Liabilities [Table Text Block]	September 30, 2017 2016 Temporary Difference Tax Effect Temporary Difference Tax Effect Deferred tax assets Net operating loss $ 1,789,958 $ 663,358 $ 1,156,331 $ 428,536 Other temporary differences 716,750 265,628 9,261 3,432 Net deferred tax assets 2,506,708 928,986 1,165,592 431,968 Valuation allowance (2,506,708 ) (928,986 ) (1,165,592 ) (431,968 ) Total deferred tax asset - - - - Deferred tax liabilities Total deferred liability - - - - Total net deferred tax asset $ - $ - $ - $ -
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	September 30, 2017 2016 U.S. Federal statutory graduated rate 34.00 % 34.00 % State income tax rate, net of federal benefit 3.06 % 3.06 % Total rate 37.06 % 37.06 % Less: Net operating loss for which no benefit is currently available (37.06 )% (37.06 )% Net effective rate 0.00 % 0.00 %

Note 9 - Equity (Tables)

Note 9 - Equity (Tables)	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017
Notes Tables
Share-based Compensation, Stock Options, Activity [Table Text Block]	Weighted Weighted Average Average Contractual Aggregate Number of Exercise Term Intrinsic Shares Price (Years) Value Outstanding and exercisable at December 31, 2017 1,305,000 $ 8.29 0.6 $ 431,200	Weighted Weighted Average Average Contractual Aggregate Number of Exercise Term Intrinsic Shares Price (Years) Value Outstanding at September 30, 2015 1,205,000 $ 8.70 1.5 $ - Granted - - - - Cancelled - - - - Exercised - - - - Outstanding at September 30, 2016 1,205,000 $ 8.70 1.5 $ - Granted 150,000 $ 2.50 4.0 - Cancelled - - - - Exercised 50,000 $ 0.75 2.0 - Outstanding as of September 30, 2017 1,305,000 $ 8.29 0.9 $ - Vested and expected to vest at September 30, 2017 1,305,000 $ 8.29 0.9 $ - Exercisable at September 30, 2017 1,305,000 $ 8.29 0.9 $ -
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	Weighted Weighted Average Average Contractual Aggregate Number of Exercise Term Intrinsic Shares Price (Years) Value Outstanding and exercisable at September 30, 2017 10,166,000 $ 3.68 2.4 $ - Granted 1,400,000 $ 1.50 4.8 Cancelled - Exercised - Outstanding as of December 31, 2017 11,566,000 $ 3.42 2.4 $ 20,461,100 Vested and expected to vest at December 31, 2017 11,566,000 $ 3.42 2.4 $ 20,461,100 Exercisable at December 31, 2017 7,826,000 $ 5.50 2.2 $ 8,954,500	Weighted Weighted Average Average Contractual Aggregate Number of Exercise Term Intrinsic Shares Price (Years) Value Outstanding at September 30, 2015 2,591,000 $ 8.92 2.7 $ - Granted 1,750,000 2.14 3.8 $ - Cancelled - - - - Exercised - - - - Outstanding at September 30, 2016 4,341,000 $ 6.19 2.1 $ - Granted 5,825,000 1.81 3.1 $ - Cancelled - - - - Exercised - - - - Outstanding as of September 30, 2017 10,166,000 $ 3.68 2.4 $ 3,756,000 Vested and expected to vest at September 30, 2017 10,166,000 $ 3.68 2.4 $ - Exercisable at September 30, 2017 6,526,000 $ 5.18 2.0 $ 480,000

Note 10 - Commitments and Con40

Note 10 - Commitments and Contingencies (Tables)	12 Months Ended
	Sep. 30, 2017
Notes Tables
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	2018 342,406 2019 341,496 2020 341,496 2021 341,496 2022 341,496 Thereafter 15,026,024 Total 16,734,414

Note 1 - Nature of Business a41

Note 1 - Nature of Business and Basis of Presentation (Tables)	3 Months Ended
	Dec. 31, 2017
Notes Tables
Cash, Cash Equivalents, and Restricted Cash [Table Text Block]	December 31, September 30, 2017 Cash and cash equivalents $ 732,355 $ 1,627 Restricted cash 365,480 - Total cash, cash equivalents, and restricted cash shown in the cash flow statement $ 1,097,835 $ 1,627

Note 3 - Notes and Other Rece42

Note 3 - Notes and Other Receivables (Tables)	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017
Notes Tables
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]	December 31, September 30, 2017 Notes and other receivables from WGP, a licensed medical marijuana cultivator; $673,294 note secured by real and personal property of the borrower, interest rate of 18.0%; accrued consulting fees of $40,000, construction advances of $332,357 and accrued interest of $206,178. Net of reserves of $469,699. All amounts are due and payable immediately. 782,130 780,315 Related party note receivable from CCI, a non-profit corporation, financing of up to $2.5 million through April 2021, interest rate of 18.0%; monthly principal and interest payments commencing the sixth month after CCI begins to generate sales; construction and working capital advances of $119,635, and accrued interest of $11,954; unsecured. 131,589 125,327 $ 913,719 $ 905,642	September 30, September 30, 2016 Note receivable from 4900 Jackson, LLC, a licensed dispensary, interest rate of 12.0%; monthly principal and interest payments of $50,000, with a balloon payment of $182,531 due on May 1, 2017; collateralized by the borrower's assets. $ - $ 247,378 Notes and other receivables from WGP, a licensed medical marijuana cultivator; $673,294 note secured by real and personal property of the borrower, interest rate of 18.0%; accrued consulting fees of $40,000, construction advances of $332,357 and accrued interest of $204,363. Net of reserves of $469,699. All amounts are due and payable immediately. 780,315 780,315 Related party note receivable from CCI, a non-profit corporation, financing of up to $2.5 million through April 2021, interest rate of 18.0%; monthly principal and interest payments commencing the sixth month after CCI begins to generate sales; construction and working capital advances of $119,635, and accrued interest of $5,692; unsecured. 125,327 57,693 905,642 1,085,386 Less: Current portion - 247,378 $ 905,642 $ 838,008

Note 7 - Loss Per Share (Tables

Note 7 - Loss Per Share (Tables)	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended December 31, 2017 2016 Net loss attributable to common stockholders $ (1,374,364 ) $ (516,765 ) Basic weighted average outstanding shares of common stock 19,366,000 18,236,435 Dilutive effects of common share equivalents - - Dilutive weighted average outstanding shares of common stock 19,366,000 18,236,435 Basic and diluted net loss per share of common stock $ (0.07 ) $ (0.03 )	Year Ended September 30, 2017 2016 Net loss attributable to common stockholders $ (2,771,894 ) $ (2,210,764 ) Basic weighted average outstanding shares of common stock 19,007,371 17,031,000 Dilutive effects of common share equivalents - - Dilutive weighted average outstanding shares of common stock 19,007,371 17,031,000 Basic and diluted net loss per share of common stock $ (0.15 ) $ (0.13 )

Note 9 - Stock Based Compensa44

Note 9 - Stock Based Compensation (Tables)	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017
Notes Tables
Share-based Compensation, Stock Options, Activity [Table Text Block]	Weighted Weighted Average Average Contractual Aggregate Number of Exercise Term Intrinsic Shares Price (Years) Value Outstanding and exercisable at December 31, 2017 1,305,000 $ 8.29 0.6 $ 431,200	Weighted Weighted Average Average Contractual Aggregate Number of Exercise Term Intrinsic Shares Price (Years) Value Outstanding at September 30, 2015 1,205,000 $ 8.70 1.5 $ - Granted - - - - Cancelled - - - - Exercised - - - - Outstanding at September 30, 2016 1,205,000 $ 8.70 1.5 $ - Granted 150,000 $ 2.50 4.0 - Cancelled - - - - Exercised 50,000 $ 0.75 2.0 - Outstanding as of September 30, 2017 1,305,000 $ 8.29 0.9 $ - Vested and expected to vest at September 30, 2017 1,305,000 $ 8.29 0.9 $ - Exercisable at September 30, 2017 1,305,000 $ 8.29 0.9 $ -

Note 11 - Shareholders' Equity

Note 11 - Shareholders' Equity (Tables)	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017
Notes Tables
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	Weighted Weighted Average Average Contractual Aggregate Number of Exercise Term Intrinsic Shares Price (Years) Value Outstanding and exercisable at September 30, 2017 10,166,000 $ 3.68 2.4 $ - Granted 1,400,000 $ 1.50 4.8 Cancelled - Exercised - Outstanding as of December 31, 2017 11,566,000 $ 3.42 2.4 $ 20,461,100 Vested and expected to vest at December 31, 2017 11,566,000 $ 3.42 2.4 $ 20,461,100 Exercisable at December 31, 2017 7,826,000 $ 5.50 2.2 $ 8,954,500	Weighted Weighted Average Average Contractual Aggregate Number of Exercise Term Intrinsic Shares Price (Years) Value Outstanding at September 30, 2015 2,591,000 $ 8.92 2.7 $ - Granted 1,750,000 2.14 3.8 $ - Cancelled - - - - Exercised - - - - Outstanding at September 30, 2016 4,341,000 $ 6.19 2.1 $ - Granted 5,825,000 1.81 3.1 $ - Cancelled - - - - Exercised - - - - Outstanding as of September 30, 2017 10,166,000 $ 3.68 2.4 $ 3,756,000 Vested and expected to vest at September 30, 2017 10,166,000 $ 3.68 2.4 $ - Exercisable at September 30, 2017 6,526,000 $ 5.18 2.0 $ 480,000

Note 1 - Description of Busin46

Note 1 - Description of Business and Significant Accounting Policies (Details Textual)	12 Months Ended		24 Months Ended
	Sep. 30, 2017USD ($)	Sep. 30, 2016USD ($)	Sep. 30, 2017USD ($)	Dec. 31, 2017USD ($)	Jan. 17, 2014
Ownership Percentage, Transfered					93.00%
Unrecognized Tax Benefits	$ 0		$ 0	$ 0
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense	0
Notes, Loans and Financing Receivable, Net, Noncurrent	780,315	$ 780,315	780,315	782,130
Allowance for Notes, Loans and Financing Receivable, Noncurrent	469,699	469,699	469,699	469,699
Assets, Fair Value Disclosure, Nonrecurring	0	0	0
Liabilities, Fair Value Disclosure, Nonrecurring	0	0	0
Assets, Fair Value Disclosure, Recurring	0	0	0
Liabilities, Fair Value Disclosure, Recurring	0	0	$ 0
Impairment of Long-Lived Assets to be Disposed of	639,497	0
Interest Costs Capitalized	$ 28,697	$ 0
Minimum [Member]
Property, Plant and Equipment, Useful Life			3 years
Maximum [Member]
Property, Plant and Equipment, Useful Life			7 years
Customer Concentration Risk [Member] | Sales Revenue, Net [Member]
Number of Major Customers	1	1
Coastal Compassion Inc. [Member]
Notes, Loans and Financing Receivable, Net, Noncurrent	$ 125,327		$ 125,327
Wellness Group Pharms LLC [Member]
Notes, Loans and Financing Receivable, Net, Noncurrent	1,250,014		1,250,014
Allowance for Notes, Loans and Financing Receivable, Noncurrent	$ 469,699	$ 469,699	$ 469,699	$ 469,699

Note 2 - Going Concern (Details

Note 2 - Going Concern (Details Textual) - USD ($)	Oct. 30, 2017	Oct. 05, 2017	Dec. 31, 2017	Dec. 31, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 12, 2017	Sep. 01, 2017
Retained Earnings (Accumulated Deficit)			$ (10,051,189)		$ (8,676,825)	$ (5,904,931)
Net Income (Loss) Attributable to Parent			(1,374,364)	$ (516,765)	(2,771,894)	(2,210,764)
Working Capital (Deficit)					(1,735,989)
Allowance for Notes, Loans and Financing Receivable, Noncurrent			469,699		469,699	469,699
Fund Requires for Operation Over the Next twelve Months					7,000,000
Parcel of Land in Denver, Colorado [Member]
Proceeds from Sale of Land Held-for-use		$ 1,760,000
Parcel of Land in Denver, Colorado [Member] | Subsequent Event [Member]
Proceeds from Sale of Land Held-for-use		$ 1,760,000
Mountain States Capital, LLC [Member]
Line of Credit Facility, Maximum Borrowing Capacity							$ 10,000,000	$ 10,000,000
Line of Credit Facility, Borrowing Capacity Available to Increase								$ 20,000,000
Unrelated Party [Member] | Construction Loans [Member]
Proceeds from Issuance of Long-term Debt	$ 800,000
Unrelated Party [Member] | Subsequent Event [Member] | Construction Loans [Member]
Proceeds from Issuance of Long-term Debt	$ 800,000
Wellness Group Pharms LLC [Member]
Notes, Loans and Financing Receivable, Gross, Noncurrent			1,251,829		1,250,014
Allowance for Notes, Loans and Financing Receivable, Noncurrent			$ 469,699		$ 469,699	$ 469,699

Note 3 - Notes Receivables - Sc

Note 3 - Notes Receivables - Schedule of Notes Receivables (Details) - USD ($)	Dec. 31, 2017	Sep. 30, 2017	Sep. 30, 2016
Notes and other receivables	$ 913,719	$ 905,642	$ 1,085,386
Total loans	913,719	905,642	1,085,386
Less: Current portion			247,378
Notes, Loans, and Financing Receivable, Net, Noncurrent		905,642	838,008
4900 Jackson LLC [Member]
Notes and other receivables			247,378
Total loans			247,378
Wellness Group Pharms LLC [Member]
Notes and other receivables	782,130	780,315	780,315
Total loans	782,130	780,315	780,315
Coastal Compassion Inc. [Member]
Notes and other receivables	131,589	125,327	57,693
Total loans	$ 131,589	$ 125,327	$ 57,693

Note 3 - Notes Receivables - 49

Note 3 - Notes Receivables - Schedule of Notes Receivables (Details) (Parentheticals) - USD ($)	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017	Sep. 30, 2016
Notes and other receivables, allowance	$ 469,699	$ 469,699	$ 469,699
4900 Jackson LLC [Member]
Interest rate		12.00%	12.00%
Monthly principal payments and interest payments		$ 50,000	$ 50,000
Balloon payment		$ 182,531	$ 182,531
Wellness Group Pharms LLC [Member]
Interest rate	18.00%	18.00%	18.00%
Secured note	$ 673,294	$ 673,294	$ 673,294
Accrued consulting fees	40,000	40,000	40,000
Construction advances	332,357	332,357	332,357
Accrued interest	206,178	204,363	204,363
Notes and other receivables, allowance	$ 469,699	$ 469,699	$ 469,699
Coastal Compassion Inc. [Member]
Interest rate	18.00%	18.00%	18.00%
Construction advances	$ 119,635	$ 119,635	$ 119,635
Accrued interest	11,954	5,692	5,692
Maximum financing amount	$ 2,500,000	$ 2,500,000	$ 2,500,000

Note 4 - Land Held for Sale (De

Note 4 - Land Held for Sale (Details Textual)	Oct. 05, 2017USD ($)	Jul. 31, 2014USD ($)a	Sep. 30, 2017USD ($)	Sep. 30, 2016USD ($)	Dec. 04, 2017a
Area of Land | a		5			5
Payments to Acquire Land Held-for-use		$ 2,250,809
Impairment of Long-Lived Assets to be Disposed of			$ 639,497	$ 0
Land			1,611,312
Assets Held-for-sale, Not Part of Disposal Group, Noncurrent			1,611,312
Parcel of Land in Denver, Colorado [Member]
Proceeds from Sale of Land Held-for-use	$ 1,760,000
Parcel of Land in Denver, Colorado [Member] | Subsequent Event [Member]
Proceeds from Sale of Land Held-for-use	$ 1,760,000
Parcel of Land in Denver, Colorado [Member]
Debt Instrument, Collateral Amount			$ 990,000

Note 5 - Notes Payable (Details

Note 5 - Notes Payable (Details Textual)	Dec. 04, 2017USD ($)	Jul. 14, 2016USD ($)$ / sharesshares	Sep. 15, 2015USD ($)	Sep. 30, 2017USD ($)$ / shares	Sep. 30, 2016USD ($)$ / sharesshares	Dec. 31, 2017USD ($)$ / shares	Dec. 31, 2016USD ($)	Dec. 31, 2017USD ($)$ / shares	Sep. 30, 2017USD ($)$ / shares	Sep. 30, 2016USD ($)$ / sharesshares	Oct. 30, 2017$ / sharesshares	Aug. 25, 2017USD ($)	Mar. 31, 2017USD ($)	Mar. 15, 2017	Sep. 15, 2016$ / sharesshares	May 01, 2016USD ($)	Apr. 06, 2016USD ($)	Feb. 01, 2016USD ($)	Sep. 30, 2015$ / shares
Gain (Loss) on Extinguishment of Debt										$ (991,939)
Interest Expense						$ 754,379	$ 81,575		$ 201,367	$ 162,834
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares				$ 3.68	$ 6.19	$ 3.42		$ 3.42	$ 3.68	$ 6.19									$ 8.92
Adjustments to Additional Paid in Capital, Warrant Issued										$ 756,637
Debt Instrument, Unamortized Discount				$ 0	$ 35,250	$ 843,452		$ 843,452	0	35,250
Proceeds from Notes Payable						1,726,000	24,657		104,657	724,544
Repayments of Notes Payable							227,904		227,904	0
Amortization of Debt Discount (Premium)						708,645	21,668		9,636	0
Strategic Capital Partners [Member]
Debt Instrument, Convertible, Conversion Price | $ / shares		$ 1.25
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares		800,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares		$ 1.50
Line of Credit Outstanding Amount Assumed by Related Party		$ 521,297
Notes Payable, Related Parties		$ 2,431,646		1,978,683	$ 2,024,297	1,931,646		1,931,646	1,978,683	2,024,297
Debt Conversion, Converted Instrument, Shares Issued | shares		400,000
Average Daily Volume Of Shares Trades | shares		100,000
Debt Instrument, Unamortized Premium		$ 72,651		47,037		41,696		41,696	47,037
Amortization of Debt Discount (Premium)						5,341	9,763		25,614	$ 0
Strategic Capital Partners [Member] | Debt Converted into Common Stock [Member]
Debt Conversion, Original Debt, Amount		500,000
Strategic Capital Partners [Member] | Debt Converted into Promissory Notes [Member]
Debt Conversion, Original Debt, Amount		$ 1,931,646
Warrants Issued to Unrelated Parties Lenders [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares					75,000					75,000	660,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares					$ 0.75					$ 0.75	$ 1.50
Adjustments to Additional Paid in Capital, Warrant Issued					$ 35,250
Debt Instrument, Unamortized Discount					$ 35,250					$ 35,250
Warrants to Purchase Additional Shares [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares					75,000					75,000					75,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares					$ 1.25					$ 1.25					$ 1.25
Warrants to Purchase Additional Shares [Member] | Strategic Capital Partners [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares		800,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares		$ 3
Average Daily Volume Of Shares Trades | shares		100,000
Warrant to Related Party, Set 1 [Member] | Strategic Capital Partners [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares		800,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares		$ 1.50
Loan Secured by Land [Member]
Repayments of Notes Payable	$ 990,000					990,000
Promissory Note One [Member] | Strategic Capital Partners [Member]
Debt Instrument, Interest Rate, Stated Percentage		9.50%
Debt Instrument, Convertible, Conversion Price | $ / shares		$ 1.25
Interest Payable				47,630					47,630
Notes Payable, Related Parties		$ 1,000,000
Convertible Debt, Number of Trading Days		20
Average Daily Volume Of Shares Trades | shares		100,000
Period to Notify End of Right to Convert Notes		10 days
Period before Right to Convert Notes Expires		45 days
Promissory Note Two [Member] | Strategic Capital Partners [Member]
Debt Instrument, Interest Rate, Stated Percentage		8.00%
Gain (Loss) on Extinguishment of Debt										$ (901,939)
Interest Payable				37,368		106,596	84,998	106,596	37,368				$ 0
Notes Payable, Related Parties		$ 931,646
Potential Buyer of Land, Held-for-sale [Member]
Proceeds from Short-term Debt			$ 900,000
Debt Instrument, Interest Rate, Stated Percentage			12.00%											18.00%			18.00%
Debt Instrument, Face Amount																	$ 990,000
Gain (Loss) on Extinguishment of Debt										(90,000)
Interest Expense									188,100	150,497
Proceeds from Notes Payable									24,657
Repayments of Notes Payable									227,904
Interest Payable				0					0
Third Party [Member] | Loan Secured by Land [Member]
Repayments of Short-term Debt			$ 650,000
Unrelated Party [Member]
Interest Expense									4,267	12,337
Long-term Line of Credit					$ 203,247					203,247
Convertible Debt				0	$ 75,000				0	$ 75,000
Debt Instrument, Convertible, Conversion Price | $ / shares					$ 0.75					$ 0.75
Debt Instrument, Unamortized Discount				0					0
Line of Credit Facility, Current Borrowing Capacity																$ 1,000,000		$ 200,000
Unrelated Party [Member] | Minimum [Member]
Debt Instrument, Interest Rate, Stated Percentage					8.00%					8.00%
Unrelated Party [Member] | Maximum [Member]
Debt Instrument, Interest Rate, Stated Percentage					18.00%					18.00%
Unrelated Party [Member] | Promissory Notes [member]
Debt Instrument, Interest Rate, Stated Percentage												12.00%
Interest Expense						3,057	$ 0		1,255	$ 0
Interest Payable				1,255		$ 4,311		4,311	$ 1,255
Line of Credit Facility, Maximum Borrowing Capacity												$ 150,000
Proceeds from Lines of Credit				$ 80,000				$ 89,677

Note 6 - Related Party Transa52

Note 6 - Related Party Transactions (Details Textual) - USD ($)	Jul. 14, 2016	Apr. 07, 2016	Dec. 31, 2017	Dec. 31, 2016	Sep. 30, 2017	Sep. 30, 2016
Interest Expense, Related Party			$ 37,390	$ 32,968	$ 143,917	$ 109,825
Interest Payable, Current			115,337		86,253	118,749
Repayments of Related Party Debt				20,000	20,000	0
Proceeds from Related Party Debt					0	247,500
Strategic Capital Partners [Member]
Notes Payable, Related Parties	$ 2,431,646		1,931,646		1,978,683	2,024,297
Debt Conversion, Converted Instrument, Shares Issued	400,000
Interest Expense, Related Party			37,390	$ 32,968	143,917	109,825
Interest Payable, Current			106,596		84,998	109,825
Interest Paid			21,133		194,358
Repayments of Related Party Debt					20,000	0
Proceeds from Related Party Debt					0	$ 247,500
Strategic Capital Partners [Member] | Notes Payable Converted to Promissory Notes [Member]
Notes Payable, Related Parties	$ 1,931,646		1,931,646		1,978,683
Strategic Capital Partners [Member] | Convertible Notes Payable [Member]
Notes Payable, Related Parties	$ 500,000
Coastal Compassion Inc. [Member]
Working Capital Advances		$ 2,500,000
Working Capital Advances, Term		5 years
Note Receivable, Interest Rate		18.00%
Consulting Services Term		3 years
Consulting Services Revenue Monthly		$ 10,000
Coastal Compassion Inc. [Member] | Construction and Working Capital Advances [Member]
Due from Related Parties			131,589		125,327
Coastal Compassion Inc. [Member] | Construction and Working Capital Advances Excluding Accrued Interest [Member]
Due from Related Parties			119,635
Coastal Compassion Inc. [Member] | Construction and Working Capital Advances Related Accrued Interest [Member]
Due from Related Parties			11,954		5,692
Coastal Compassion Inc. [Member] | Maximum [Member]
Working Capital Advances		$ 2,500,000
Construction and Working Capital Advances [Member] | Construction and Working Capital Advances Excluding Accrued Interest [Member]
Due from Related Parties			$ 119,635		$ 119,635

Note 7 - Earnings Per Share (De

Note 7 - Earnings Per Share (Details Textual) - shares	3 Months Ended		12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Sep. 30, 2017	Sep. 30, 2016
Employee Stock Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	1,305,000	1,205,000	1,305,000	1,205,000
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	11,566,000	9,981,000	10,166,000	4,341,000

Note 7 - Earnings Per Share - S

Note 7 - Earnings Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($)	3 Months Ended		12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Sep. 30, 2017	Sep. 30, 2016
Net loss	$ (1,374,364)	$ (516,765)	$ (2,771,894)	$ (2,210,764)
Basic weighted average outstanding shares of common stock (in shares)	19,366,000	18,236,435	19,007,371	17,031,000
Dilutive effects of common share equivalents (in shares)	0	0	0	0
Dilutive weighted average outstanding shares of common stock (in shares)	19,366,000	18,236,435	19,007,371	17,031,000
Basic and diluted loss per common share (in dollars per share)	$ (0.07)	$ (0.03)	$ (0.15)	$ (0.13)

Note 8 - Income Taxes (Details

Note 8 - Income Taxes (Details Textual) - USD ($)	12 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Operating Loss Carryforwards	$ 4,370,404	$ 2,551,748
Deferred Tax Assets, Gross	$ 928,986	431,968
Deferred Tax Assets, Valuation Allowance, Percent Offset	100.00%
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	$ 497,018	$ 27,396

Note 8 - Income Taxes - Deferre

Note 8 - Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Sep. 30, 2016
Deferred tax assets	$ 0	$ 0
Deferred tax liabilities	0	0
Net deferred tax assets/(liabilities)	$ 0	$ 0

Note 8 - Income Taxes - Tempora

Note 8 - Income Taxes - Temporary Differences Between Basis and Reported Deferred Tax Assets (Details) - USD ($)	Sep. 30, 2017	Sep. 30, 2016
Net operating loss, temporary difference	$ 1,789,958	$ 1,156,331
Net operating loss	663,358	428,536
Other temporary differences, temporary difference	716,750	9,261
Other temporary differences	265,628	3,432
Net deferred tax assets, temporary difference	2,506,708	1,165,592
Net deferred tax assets	928,986	431,968
Valuation allowance, temporary difference	(2,506,708)	(1,165,592)
Valuation allowance	(928,986)	(431,968)
Total deferred tax asset	0	0
Deferred tax liabilities	0	0
Net deferred tax assets/(liabilities)	$ 0	$ 0

Note 8 - Income Taxes - Schedul

Note 8 - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)	12 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
U.S. Federal statutory graduated rate	34.00%	34.00%
State income tax rate, net of federal benefit	3.06%	3.06%
Total rate	37.06%	37.06%
Less: Net operating loss for which no benefit is currently available	(37.06%)	(37.06%)
Net effective rate	0.00%	0.00%

Note 9 - Equity (Details Textua

Note 9 - Equity (Details Textual) - USD ($)	Sep. 01, 2017	Aug. 18, 2017	Mar. 21, 2017	Nov. 07, 2016	Oct. 17, 2016	Jul. 14, 2016	Feb. 19, 2015	Sep. 30, 2017	Dec. 31, 2017	Sep. 30, 2017	Dec. 31, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 12, 2017	Sep. 15, 2016	Sep. 30, 2015
Preferred Stock, Shares Authorized								20,000,000	20,000,000	20,000,000		20,000,000	20,000,000
Preferred Stock, Par or Stated Value Per Share								$ 0.0001	$ 0.0001	$ 0.0001		$ 0.0001	$ 0.0001
Preferred Stock, Shares Outstanding								0	0	0		0	0
Equity Units, Value, Subscriptions				$ 2,000,000				$ 185,000		$ 185,000		$ 185,000
Equity Units, Price Per Unit				$ 1				$ 2		$ 2		$ 2
Equity Units, Number of Shares of Common Stock in Each Unit				1				1		1		1
Class of Warrant or Right, Exercise Price of Warrants or Rights								$ 3.68	$ 3.42	$ 3.68		$ 3.68	$ 6.19			$ 8.92
Equity Units, Subscribed But Unissued, Gross Proceeds Receivable				$ 2,000,000				$ 370,000		$ 370,000		$ 370,000
Payments of Stock Issuance Costs				$ 193,726
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period												50,000
Proceeds from Stock Options Exercised												$ 37,500	$ 0
Allocated Share-based Compensation Expense												37,450	$ 131,075
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized								$ 0		$ 0		$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number								1,305,000		1,305,000		1,305,000
Common Stock, Par or Stated Value Per Share								$ 0.0001	$ 0.0001	$ 0.0001		$ 0.0001	$ 0.0001
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross												150,000	0
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price												$ 2.50
Employee Stock Option [Member]
Allocated Share-based Compensation Expense									$ 0		$ 0
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized									0
Stock Incentive Plan [Member]
Allocated Share-based Compensation Expense		$ 222,988										$ 222,988	$ 9,173
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized		1,500,000
Stock Incentive Plan [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate		1.62%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term		4 years
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate		179.00%
Sale Leaseback to MMP [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights					$ 1									$ 1
Stock Issued During Period, Shares, Issued to Lessor					100,000
Common Stock, Par or Stated Value Per Share					$ 0.0001
Class of Warrant or Right, Number of Securities Called by Warrants or Rights					3,640,000
Average Daily Volume Of Shares Trades					100,000
General and Administrative Expense [Member]
Other Depreciation and Amortization												0	$ 5,708
Investment Relations Consulting Agreement [Member]
Stock Issued During Period, Shares, New Issues							50,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares							25,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number							25,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value							$ 34,250
Chief Executive Officer [Member]
Sale of Stock, Number of Shares Issued in Transaction													1,200,000
Sale of Stock, Price Per Share													$ 0.001
Share Price													$ 0.75
Allocated Share-based Compensation Expense, Difference of Fair Market Value and Purchase Price													$ 898,800
Allocated Share-based Compensation Expense												37,450	$ 131,075
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized								$ 0		$ 0		0
Consultants [Member] | Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		150,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price		$ 2.50
Equity Line Agreement [Member]
Stock Issued During Period, Shares, New Issues								0
Purchase Price of Weighted Average Price of Common Stock	90.00%													90.00%
Percentage of Closing Price of Common Stock	75.00%													75.00%
Mountain States Capital, LLC [Member]
Line of Credit Facility, Maximum Borrowing Capacity	$ 10,000,000													$ 10,000,000
Line of Credit Facility, Borrowing Capacity Available to Increase	20,000,000
Line of Credit Facility, Current Borrowing Capacity	$ 500,000													$ 500,000
Debt Instrument, Term	1 year 180 days
Long-term Line of Credit								$ 0		$ 0		$ 0
Three Unrelated Parties [Member]
Long-term Line of Credit															$ 25,000
Common Stock [Member]
Stock Issued During Period, Shares, New Issues			50,000										400,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period			50,000									50,000
Proceeds from Stock Options Exercised			$ 37,500
Stock Issued During Period, Shares, Issued to Lessor												100,000
Series I Warrants [Member]
Equity Units, Number of Warrants in Each Unit				1
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right				1
Class of Warrant or Right, Exercise Price of Warrants or Rights				$ 3
Class of Warrant or Right, Fair Value of Warrant Issued, Percent				43.00%
Equity Units, Subscribed But Unissued, Potentially Receivable Additional Proceeds				$ 6,000,000
Series V Warrants [Member]
Equity Units, Number of Warrants in Each Unit								1		1		1
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right								1		1		1
Class of Warrant or Right, Exercise Price of Warrants or Rights								$ 5		$ 5		$ 5
Class of Warrant or Right, Fair Value of Warrant Issued, Percent										48.00%		48.00%
Equity Units, Subscribed But Unissued, Potentially Receivable Additional Proceeds								$ 925,000		$ 925,000		$ 925,000
Warrants to Purchase Additional Shares [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights													$ 1.25		$ 1.25
Class of Warrant or Right, Number of Securities Called by Warrants or Rights													75,000		75,000
Unrelated Party [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights															$ 0.75
Class of Warrant or Right, Number of Securities Called by Warrants or Rights															75,000
Strategic Capital Partners [Member]
Notes Payable, Related Parties						$ 2,431,646		$ 1,978,683	$ 1,931,646	$ 1,978,683		$ 1,978,683	$ 2,024,297
Debt Conversion, Converted Instrument, Shares Issued						400,000
Debt Instrument, Convertible, Conversion Price						$ 1.25
Class of Warrant or Right, Exercise Price of Warrants or Rights						$ 1.50
Class of Warrant or Right, Number of Securities Called by Warrants or Rights						800,000
Class of Warrant or Right Expiration Term						45 days
Number of Consecutive Trading Days						20 days
Average Daily Volume Of Shares Trades						100,000
Strategic Capital Partners [Member] | Minimum [Member]
Average Closing Price per Share						$ 3
Strategic Capital Partners [Member] | Warrants to Purchase Additional Shares [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights						3
Share Price						$ 1.02
Class of Warrant or Right, Number of Securities Called by Warrants or Rights						800,000
Class of Warrant or Right, Issued During Period, Value						$ 410,328
Fair Value Assumptions, Exercise Price						$ 3
Fair Value Assumptions, Expected Term						4 years
Fair Value Assumptions, Risk Free Interest Rate						0.96%
Fair Value Assumptions, Expected Volatility Rate						100.00%
Fair Value Assumptions, Expected Dividend Rate						0.00%			0.00%
Class of Warrant or Right Expiration Term						45 days
Average Closing Price per Share						$ 4.80
Number of Consecutive Trading Days						20 days
Average Daily Volume Of Shares Trades						100,000
Strategic Capital Partners [Member] | Warrants to Purchase Additional Shares [Member] | Minimum [Member]
Fair Value Assumptions, Exercise Price									$ 1.74
Fair Value Assumptions, Expected Term									3 years
Fair Value Assumptions, Risk Free Interest Rate									1.73%
Fair Value Assumptions, Expected Volatility Rate									163.00%
Strategic Capital Partners [Member] | Warrants to Purchase Shares [Member]
Share Price						$ 1.02
Class of Warrant or Right, Issued During Period, Value						$ 510,960
Fair Value Assumptions, Exercise Price						$ 1.25
Fair Value Assumptions, Expected Term						4 years
Fair Value Assumptions, Risk Free Interest Rate						0.96%
Fair Value Assumptions, Expected Volatility Rate						100.00%
Fair Value Assumptions, Expected Dividend Rate						0.00%
Strategic Capital Partners [Member] | Convertible Notes Payable [Member]
Notes Payable, Related Parties						$ 500,000

Note 9 - Equity - Stock Option

Note 9 - Equity - Stock Option Activity (Details) - $ / shares	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2015
Shares Outstanding (in shares)	1,305,000	1,205,000	1,205,000
Outstanding, weighted average exercise price (in dollars per share)	$ 8.29	$ 8.70	$ 8.70
Outstanding, weighted average contractual term (Year)	219 days	328 days	1 year 182 days	1 year 182 days
Shares Granted (in shares)		150,000	0
Granted, weighted average exercise price (in dollars per share)		$ 2.50
Granted, weighted average contractual term (Year)		4 years
Stock issued for options exercised (in shares)		50,000
Exercised, weighted average exercise price (in dollars per share)		$ 0.75
Exercised, weighted average contractual term (Year)		2 years
Shares Outstanding (in shares)	1,305,000	1,305,000	1,205,000	1,205,000
Outstanding, weighted average exercise price (in dollars per share)	$ 8.29	$ 8.29	$ 8.70	$ 8.70
Shares Vested and expected to vest (in shares)		1,305,000
Vested and expected to vest, weighted average exercise price (in dollars per share)		$ 8.29
Vested and expected to vest, weighted average contractual term (Year)		328 days
Shares Exercisable (in shares)		1,305,000
Exercisable, weighted average exercise price (in dollars per share)		$ 8.29
Exercisable, weighted average contractual term (Year)		328 days

Note 9 - Equity - Warrant Activ

Note 9 - Equity - Warrant Activity (Details) - USD ($)	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2015
Outstanding, warrants (in shares)	10,166,000	4,341,000	2,591,000
Outstanding, warrants, weighted average exercise price (in dollars per share)	$ 3.68	$ 6.19	$ 8.92
Outstanding, warrants, weighted average remaining contract term (Year)	2 years 146 days	2 years 146 days	2 years 36 days	2 years 255 days
Granted, warrants (in shares)	1,400,000	5,825,000	1,750,000
Granted, warrants, weighted average exercise price (in dollars per share)	$ 1.50	$ 1.81	$ 2.14
Granted, warrants, weighted average remaining contract term (Year)	4 years 292 days	3 years 36 days	3 years 292 days
Outstanding, warrants (in shares)	11,566,000	10,166,000	4,341,000	2,591,000
Outstanding, warrants, weighted average exercise price (in dollars per share)	$ 3.42	$ 3.68	$ 6.19	$ 8.92
Class of warrant or right, outstanding, aggregate intrinsic value	$ 20,461,100	$ 3,756,000
Vested and expected to vest, warrants (in shares)	11,566,000	10,166,000
Vested and expected to vest, warrants, weighted average exercise price (in dollars per share)	$ 3.42	$ 3.68
Vested and expected to vest , weighted average remaining contract term (Year)	2 years 146 days	2 years 146 days
Class of warrant or right, vested and expected to vest, aggregate intrinsic value	$ 20,461,100
Exercisable, warrants (in shares)	7,826,000	6,526,000
Exercisable, warrants, weighted average exercise price (in dollars per share)	$ 5.50	$ 5.18
Exercisable, warrants, weighted average remaining contract term (Year)	2 years 73 days	2 years
Class of warrant or right, exercisable, aggregate intrinsic value	$ 8,954,500	$ 480,000

Note 10 - Commitments and Con62

Note 10 - Commitments and Contingencies (Details Textual)	Feb. 16, 2018USD ($)$ / sharesshares	Oct. 17, 2017USD ($)$ / sharesshares	Oct. 17, 2016USD ($)a$ / shares$ / itemshares	Dec. 01, 2014USD ($)	Oct. 04, 2014USD ($)	Jul. 31, 2014USD ($)a	Mar. 25, 2014USD ($)	Dec. 31, 2017USD ($)$ / shares	Dec. 31, 2016USD ($)	Sep. 30, 2017USD ($)$ / shares	Sep. 30, 2016USD ($)$ / shares	Sep. 30, 2016USD ($)$ / shares	Sep. 30, 2016USD ($)$ / shares	Dec. 12, 2017$ / shares	Dec. 04, 2017a	Sep. 30, 2015$ / shares	Jan. 14, 2015USD ($)a
Area of Land | a						5									5
Payments to Acquire Land Held-for-use						$ 2,250,809
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares								$ 3.42		$ 3.68	$ 6.19	$ 6.19	$ 6.19			$ 8.92
Common Stock, Par or Stated Value Per Share | $ / shares								$ 0.0001		$ 0.0001	$ 0.0001	$ 0.0001	$ 0.0001
Security Deposit								$ 3,110		$ 3,110	$ 3,110	$ 3,110	$ 3,110
Operating Leases, Office Space [Member]
Operating Leases, Rent Expense, Net										35,610	35,145
Operating Leases, Monthly Payment								1,845		2,920
Security Deposit										3,110
Operating Leases, Automobile [Member]
Lessee, Operating Lease, Term of Contract					3 years 90 days
Operating Leases, Rent Expense, Net										7,390	7,483
Operating Leases, Monthly Payment					$ 611
Additional Paid-in Capital [Member]
Warrants Issued During Period, Value, Sale Leaseback Transaction			$ 1,972,966
Stock Issued During Period, Value, Sale Leaseback Transaction			73,000
Warrants Issued for Lease Amendment [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares		100,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares		$ 1.50
Subsequent Event [Member] | Warrants Issued for Lease Amendment [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares	50,000	100,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares	$ 1.50	$ 1.50
Sale Leaseback to MMP [Member]
Payments to Acquire Land			$ 925,000
Lessee, Operating Lease, Term of Contract			50 years
Lessee Leasing Arrangements, Operating Leases, Number of Renewal Periods			4
Lessee, Operating Lease, Renewal Term			10 years
Sale Leaseback Transaction, Monthly Rental Payments			$ 30,000
Sale Leaseback Transaction, Monthly Rental Payments, Per Square Foot | $ / item			0.38
Sale Leaseback Transaction, Monthly Rental Payments, Percentage of Gross Monthly Sales			1.50%
Sale Leaseback Transaction, Monthly Rental Payments, Adjustment Period			5 years
Sale Leaseback Transaction, Period Available to Obtain Capital Funding for Construction of the First Phase Building		1 year 120 days	180 days
Sales Leaseback Transaction, Amount of Capital Funding to Obtain For Construction of the First Phase Building		$ 2,600,000	$ 2,600,000
Sale Leaseback Transaction, Additional Period Available to Obtain Capital Funding for Construction of the First Phase Building			180 days
Sale Leaseback Transaction, Period Unable to Obtain Capital Funding for Construction of the First Phase Building, After Which the Arrangement Will Terminate			1 year
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares			3,640,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares			$ 1											$ 1
Sale Leaseback Transaction, Discount to the Purchase Price, Monthly Reduction in Payments			$ 1,542
Stock Issued During Period, Shares, Sale Leaseback Transaction | shares			100,000
Common Stock, Par or Stated Value Per Share | $ / shares			$ 0.0001
Sale Leaseback to MMP [Member] | Warrant [Member]
Fair Value Assumptions, Risk Free Interest Rate			1.12%
Fair Value Assumptions, Expected Term			4 years
Fair Value Assumptions, Expected Volatility Rate			115.00%
Sale Leaseback to MMP [Member] | Subsequent Event [Member]
Sale Leaseback Transaction, Period Available to Obtain Capital Funding for Construction of the First Phase Building	1 year 180 days	1 year 120 days
Sales Leaseback Transaction, Amount of Capital Funding to Obtain For Construction of the First Phase Building	$ 2,600,000	$ 2,600,000
Investment Relations Consulting Agreement [Member]
Monthly Consulting Services Payment				$ 4,000
Massachusetts Land Purchase [Member]
Area of Land | a			52.6														52.6
Deposits on Land																	$ 100,000
Land, Selling Price			$ 4,475,000									4,325,000
Payments to Acquire Land												$ 725,000	$ 925,000
Land Purchase, Previous Payments Credited Against the Total Purchase Price			925,000
Payments to Acquire Land Held-for-use			$ 3,550,000
Operating Leases, Rent Expense, Net								$ 108,625	$ 98,852	$ 506,765	$ 0
Chief Executive Officer [Member]
Officer Employment Agreement, Initial Term							3 years
Chief Executive Officer [Member] | Officer Employment Agreement [Member]
Officer Employment Agreement, Time Devoted, Percentage							50.00%
Officer Employment Agreement, Monthly Payment							$ 12,000

Note 10 - Commitments and Con63

Note 10 - Commitments and Contingencies - Future Rental Payments Under Operating Leases (Details)	Sep. 30, 2017USD ($)
2,018	$ 342,406
2,019	341,496
2,020	341,496
2,021	341,496
2,022	341,496
Thereafter	15,026,024
Total	$ 16,734,414

Note 11 - Subsequent Events (De

Note 11 - Subsequent Events (Details Textual)	Feb. 16, 2018USD ($)$ / sharesshares	Nov. 13, 2017USD ($)$ / shares	Oct. 30, 2017USD ($)$ / sharesshares	Oct. 17, 2017USD ($)$ / sharesshares	Oct. 05, 2017USD ($)$ / shares	Oct. 17, 2016USD ($)a$ / sharesshares	Dec. 31, 2017$ / shares	Dec. 12, 2017$ / shares	Dec. 04, 2017a	Sep. 30, 2017$ / shares	Sep. 30, 2016$ / sharesshares	Sep. 30, 2015$ / shares	Jan. 14, 2015a	Jul. 31, 2014a
Class of Warrant or Right, Exercise Price of Warrants or Rights							$ 3.42			$ 3.68	$ 6.19	$ 8.92
Area of Land | a									5					5
Sale Leaseback to MMP [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares						3,640,000
Class of Warrant or Right, Exercise Price of Warrants or Rights						$ 1		$ 1
Lessee, Operating Lease, Term of Contract						50 years
Sale Leaseback Transaction, Period Available to Obtain Capital Funding for Construction of the First Phase Building				1 year 120 days		180 days
Sales Leaseback Transaction, Amount of Capital Funding to Obtain For Construction of the First Phase Building | $				$ 2,600,000		$ 2,600,000
Massachusetts Land Purchase [Member]
Area of Land | a						52.6							52.6
Warrants Issued to Unrelated Parties Lenders [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares			660,000								75,000
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 1.50								$ 0.75
Warrants Issued for Lease Amendment [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares				100,000
Class of Warrant or Right, Exercise Price of Warrants or Rights				$ 1.50
Subsequent Event [Member] | Sale Leaseback to MMP [Member]
Sale Leaseback Transaction, Period Available to Obtain Capital Funding for Construction of the First Phase Building	1 year 180 days			1 year 120 days
Sales Leaseback Transaction, Amount of Capital Funding to Obtain For Construction of the First Phase Building | $	$ 2,600,000			$ 2,600,000
Subsequent Event [Member] | Warrants Issued to Unrelated Parties Lenders [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares			660,000
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 1.50
Subsequent Event [Member] | Warrants Issued for Lease Amendment [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares	50,000			100,000
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 1.50			$ 1.50
Unrelated Party [Member]
Debt Instrument, Convertible, Conversion Price											$ 0.75
Unrelated Party [Member] | Minimum [Member]
Debt Instrument, Interest Rate, Stated Percentage											8.00%
Unrelated Party [Member] | Maximum [Member]
Debt Instrument, Interest Rate, Stated Percentage											18.00%
Unrelated Party [Member] | Construction Loans [Member]
Proceeds from Issuance of Long-term Debt | $			$ 800,000
Debt Instrument, Interest Rate, Stated Percentage			8.00%
Debt Instrument, Convertible, Conversion Price			$ 1.50
Unrelated Party [Member] | Subsequent Event [Member] | Convertible Debt [Member]
Proceeds from Issuance of Long-term Debt | $		$ 68,000			$ 128,000
Debt Instrument, Interest Rate, Stated Percentage		12.00%			12.00%
Debt Instrument, Conversion Price, Market Price		$ 1.35			$ 1.35
Debt Instrument, Variable Conversion Price, Input, Percentage		65.00%			65.00%
Debt Instrument, Fixed Conversion Price		1			1
Unrelated Party [Member] | Subsequent Event [Member] | Convertible Debt [Member] | Minimum [Member]
Debt Instrument, Prepay, Premiums, Percentage		15.00%			15.00%
Unrelated Party [Member] | Subsequent Event [Member] | Convertible Debt [Member] | Maximum [Member]
Debt Instrument, Prepay, Premiums, Percentage		35.00%			35.00%
Unrelated Party [Member] | Subsequent Event [Member] | Construction Loans [Member]
Proceeds from Issuance of Long-term Debt | $			$ 800,000
Debt Instrument, Interest Rate, Stated Percentage			8.00%
Debt Instrument, Convertible, Conversion Price			$ 1.50

Note 1 - Nature of Business a65

Note 1 - Nature of Business and Basis of Presentation (Details Textual)	Jan. 17, 2014
Ownership Percentage, Transfered	93.00%

Note 1 - Nature of Business a66

Note 1 - Nature of Business and Basis of Presentation - Restricted Cash (Details) - USD ($)	Dec. 31, 2017	Sep. 30, 2017	Dec. 31, 2016	Sep. 30, 2016	Sep. 30, 2015
Cash and cash equivalents	$ 732,355	$ 1,627		$ 24	$ 201,353
Restricted cash	365,480
Total cash, cash equivalents, and restricted cash shown in the cash flow statement	$ 1,097,835	$ 1,627	$ 802,769	$ 24

Note 2 - Going Concern (Detai67

Note 2 - Going Concern (Details Textual) - USD ($)	Jan. 18, 2018	Dec. 31, 2017	Dec. 31, 2016	Sep. 30, 2017	Sep. 30, 2016
Retained Earnings (Accumulated Deficit)		$ (10,051,189)		$ (8,676,825)	$ (5,904,931)
Net Income (Loss) Attributable to Parent		(1,374,364)	$ (516,765)	(2,771,894)	(2,210,764)
Allowance for Notes, Loans and Financing Receivable, Noncurrent		469,699		469,699	469,699
Subsequent Event [Member] | Demand for Arbitration against WGP [Member]
Litigation Settlement, Amount Awarded from Other Party	$ 1,045,000
Litigation Settlement, Amount Awarded Receivable from Other Party, Interest Rate	18.00%
Litigation Settlement Interest	$ (523,023)
Litigation Settlement, Amount Awarded from Other Party, Including Interest	$ 1,568,023
Wellness Group Pharms LLC [Member]
Notes, Loans and Financing Receivable, Gross, Noncurrent		1,251,829		1,250,014
Allowance for Notes, Loans and Financing Receivable, Noncurrent		$ 469,699		$ 469,699	$ 469,699

Note 3 - Notes and Other Rece68

Note 3 - Notes and Other Receivables - Schedule of Notes Receivables (Details) - USD ($)	Dec. 31, 2017	Sep. 30, 2017	Sep. 30, 2016
Notes and other receivables	$ 913,719	$ 905,642	$ 1,085,386
Wellness Group Pharms LLC [Member]
Notes and other receivables	782,130	780,315	780,315
Coastal Compassion Inc. [Member]
Notes and other receivables	$ 131,589	$ 125,327	$ 57,693

Note 3 - Notes and Other Rece69

Note 3 - Notes and Other Receivables - Schedule of Notes Receivables (Details) (Parentheticals) - USD ($)	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017	Sep. 30, 2016
Notes and other receivables, allowance	$ 469,699	$ 469,699	$ 469,699
Wellness Group Pharms LLC [Member]
Secured note	$ 673,294	$ 673,294	$ 673,294
Interest rate	18.00%	18.00%	18.00%
Accrued consulting fees	$ 40,000	$ 40,000	$ 40,000
Construction advances	332,357	332,357	332,357
Accrued interest	206,178	204,363	204,363
Notes and other receivables, allowance	$ 469,699	$ 469,699	$ 469,699
Coastal Compassion Inc. [Member]
Interest rate	18.00%	18.00%	18.00%
Construction advances	$ 119,635	$ 119,635	$ 119,635
Accrued interest	11,954	5,692	5,692
Maximum financing amount	$ 2,500,000	$ 2,500,000	$ 2,500,000

Note 4 - Land (Details Textual)

Note 4 - Land (Details Textual)	Dec. 04, 2017USD ($)a	Oct. 05, 2017USD ($)	Jul. 31, 2014USD ($)a	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)	Sep. 30, 2017USD ($)	Sep. 30, 2016USD ($)
Area of Land | a	5		5
Payments to Acquire Land Held-for-use			$ 2,250,809
Land						$ 1,611,312
Assets Held-for-sale, Not Part of Disposal Group, Noncurrent						1,611,312
Gain (Loss) on Disposition of Property Plant Equipment				$ (2,861)
Repayments of Notes Payable					227,904	227,904	$ 0
Interest Paid, Net				54,040	$ 164,450	$ 396,841	$ 151,925
Unrelated Party [Member] | Construction Loans [Member]
Repayments of Notes Payable	$ 601,363
Debt Instrument, Face Amount	800,000
Loan Secured by Land [Member]
Repayments of Notes Payable	990,000			$ 990,000
Interest Paid, Net	17,088
Land [Member]
Gain (Loss) on Disposition of Property Plant Equipment	$ (2,861)
Parcel of Land in Denver, Colorado [Member]
Proceeds from Sale of Land Held-for-use		$ 1,760,000

Note 5 - Notes Payable (Detai71

Note 5 - Notes Payable (Details Textual)	Dec. 29, 2017USD ($)$ / sharesshares	Dec. 04, 2017USD ($)a	Nov. 13, 2017USD ($)$ / shares	Oct. 30, 2017USD ($)$ / sharesshares	Oct. 05, 2017USD ($)$ / shares	Jul. 14, 2016USD ($)$ / sharesshares	Sep. 30, 2017USD ($)$ / shares	Sep. 30, 2016USD ($)$ / sharesshares	Dec. 31, 2017USD ($)$ / shares	Dec. 31, 2016USD ($)	Dec. 31, 2017USD ($)$ / shares	Sep. 30, 2017USD ($)$ / shares	Sep. 30, 2016USD ($)$ / sharesshares	Aug. 25, 2017USD ($)	Mar. 31, 2017USD ($)	Sep. 15, 2016$ / sharesshares	May 01, 2016USD ($)	Feb. 01, 2016USD ($)	Sep. 30, 2015$ / shares	Jul. 31, 2014a
Area of Land | a		5																		5
Repayments of Notes Payable										$ 227,904		$ 227,904	$ 0
Interest Expense									754,379	81,575		201,367	162,834
Amortization of Debt Discount (Premium)									$ 708,645	21,668		$ 9,636	$ 0
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares							$ 3.68	$ 6.19	$ 3.42		$ 3.42	$ 3.68	$ 6.19						$ 8.92
Debt Instrument, Unamortized Discount							$ 0	$ 35,250	$ 843,452		$ 843,452	$ 0	$ 35,250
Adjustments to Additional Paid in Capital, Warrant Issued													756,637
Strategic Capital Partners [Member]
Amortization of Debt Discount (Premium)									5,341	9,763		25,614	0
Debt Instrument, Convertible, Conversion Price | $ / shares						$ 1.25
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares						800,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares						$ 1.50
Line of Credit Outstanding Amount Assumed by Related Party						$ 521,297
Notes Payable, Related Parties						$ 2,431,646	1,978,683	$ 2,024,297	1,931,646		1,931,646	1,978,683	$ 2,024,297
Debt Conversion, Converted Instrument, Shares Issued | shares						400,000
Average Daily Volume Of Shares Trades | shares						100,000
Debt Instrument, Unamortized Premium						$ 72,651	47,037		41,696		41,696	47,037
Strategic Capital Partners [Member] | Debt Converted into Common Stock [Member]
Debt Conversion, Original Debt, Amount						500,000
Strategic Capital Partners [Member] | Debt Converted into Promissory Notes [Member]
Debt Conversion, Original Debt, Amount						$ 1,931,646
GVC Capital LLC [Member]
Debt Instrument, Unamortized Discount	$ 15,438
Payments of Debt Issuance Costs	64,000
Adjustments to Additional Paid in Capital, Warrant Issued	$ 48,562
Warrants Issued to Unrelated Parties Lenders [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares				660,000				75,000					75,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares				$ 1.50				$ 0.75					$ 0.75
Debt Instrument, Unamortized Discount								$ 35,250					$ 35,250
Adjustments to Additional Paid in Capital, Warrant Issued								$ 35,250
Warrants Issued to Accredited Investors [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares	533,333
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares	$ 1.50
Warrants Issued to Placement Agent [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares	106,667
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares	$ 1.50
Warrant to Related Party, Set 1 [Member] | Strategic Capital Partners [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares						800,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares						$ 1.50
Warrants to Purchase Additional Shares [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares								75,000					75,000			75,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares								$ 1.25					$ 1.25			$ 1.25
Warrants to Purchase Additional Shares [Member] | Strategic Capital Partners [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares						800,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares						$ 3
Average Closing Price per Share | $ / shares						$ 4.80
Average Daily Volume Of Shares Trades | shares						100,000
Minimum [Member] | Strategic Capital Partners [Member]
Average Closing Price per Share | $ / shares						$ 3
Unrelated Party [Member]
Interest Expense												4,267	$ 12,337
Debt Instrument, Convertible, Conversion Price | $ / shares								$ 0.75					$ 0.75
Debt Instrument, Unamortized Discount							0					0
Line of Credit Facility, Current Borrowing Capacity																	$ 1,000,000	$ 200,000
Unrelated Party [Member] | Minimum [Member]
Debt Instrument, Interest Rate, Stated Percentage								8.00%					8.00%
Unrelated Party [Member] | Maximum [Member]
Debt Instrument, Interest Rate, Stated Percentage								18.00%					18.00%
Unrelated Party [Member] | Construction Loans [Member]
Repayments of Notes Payable		$ 601,363
Debt Instrument, Interest Rate, Stated Percentage				8.00%
Proceeds from Issuance of Long-term Debt				$ 800,000
Debt Instrument, Convertible, Beneficial Conversion Feature				$ 357,612
Amortization of Debt Discount (Premium)									712,736	0
Debt Instrument, Convertible, Conversion Price | $ / shares				$ 1.50
Debt Instrument, Unamortized Discount				$ 442,388
Debt Instrument, Face Amount		800,000
Loan Secured by Land [Member]
Repayments of Notes Payable		$ 990,000							990,000
Promissory Notes [member] | Unrelated Party [Member]
Line of Credit Facility, Maximum Borrowing Capacity														$ 150,000
Debt Instrument, Interest Rate, Stated Percentage														12.00%
Proceeds from Lines of Credit							80,000				89,677
Interest Payable							1,255		4,311		4,311	1,255
Interest Expense									3,057	0		1,255	$ 0
Loans Due and Payable on October 5, 2018 [Member] | Unrelated Party [Member] | Convertible Debt [Member]
Debt Instrument, Interest Rate, Stated Percentage					12.00%
Proceeds from Issuance of Long-term Debt					$ 128,000
Debt Instrument, Conversion Price, Market Price | $ / shares					$ 1.35
Debt Instrument, Variable Conversion Price, Input, Percentage					65.00%
Debt Instrument, Fixed Conversion Price					1
Debt Instrument, Convertible, Beneficial Conversion Feature					$ 3,000
Amortization of Debt Discount (Premium)									750	0
Loans Due and Payable on October 5, 2018 [Member] | Unrelated Party [Member] | Convertible Debt [Member] | Minimum [Member]
Debt Instrument, Prepay, Premiums, Percentage					15.00%
Loans Due and Payable on October 5, 2018 [Member] | Unrelated Party [Member] | Convertible Debt [Member] | Maximum [Member]
Debt Instrument, Prepay, Premiums, Percentage					35.00%
Loans Due and Payable on November 13, 2018 [Member] | Unrelated Party [Member] | Convertible Debt [Member]
Debt Instrument, Interest Rate, Stated Percentage			12.00%
Proceeds from Issuance of Long-term Debt			$ 68,000
Debt Instrument, Conversion Price, Market Price | $ / shares			$ 1.35
Debt Instrument, Variable Conversion Price, Input, Percentage			65.00%
Debt Instrument, Fixed Conversion Price			1
Debt Instrument, Convertible, Beneficial Conversion Feature			$ 3,000
Amortization of Debt Discount (Premium)									500	0
Loans Due and Payable on November 13, 2018 [Member] | Unrelated Party [Member] | Convertible Debt [Member] | Minimum [Member]
Debt Instrument, Prepay, Premiums, Percentage			15.00%
Loans Due and Payable on November 13, 2018 [Member] | Unrelated Party [Member] | Convertible Debt [Member] | Maximum [Member]
Debt Instrument, Prepay, Premiums, Percentage			35.00%
Notes Due and Payable on December 31, 2018 [Member] | Accredited Investors [Member] | Convertible Debt [Member]
Debt Instrument, Interest Rate, Stated Percentage	8.00%
Debt Instrument, Convertible, Beneficial Conversion Feature	$ 128,976
Amortization of Debt Discount (Premium)									0
Debt Instrument, Convertible, Conversion Price | $ / shares	$ 1.50
Debt Instrument, Unamortized Discount	$ 607,024
Debt Instrument, Face Amount	$ 800,000
Promissory Note One [Member] | Strategic Capital Partners [Member]
Debt Instrument, Interest Rate, Stated Percentage						9.50%
Interest Payable							47,630					47,630
Debt Instrument, Convertible, Conversion Price | $ / shares						$ 1.25
Notes Payable, Related Parties						$ 1,000,000
Average Closing Price per Share | $ / shares						$ 2.50
Convertible Debt, Number of Trading Days						20
Average Daily Volume Of Shares Trades | shares						100,000
Period to Notify End of Right to Convert Notes						10 days
Period before Right to Convert Notes Expires						45 days
Promissory Note Two [Member] | Strategic Capital Partners [Member]
Debt Instrument, Interest Rate, Stated Percentage						8.00%
Interest Payable							$ 37,368		$ 106,596	$ 84,998	$ 106,596	$ 37,368			$ 0
Notes Payable, Related Parties						$ 931,646

Note 6 - Related Party Transa72

Note 6 - Related Party Transactions (Details Textual) - USD ($)	Apr. 07, 2016	Dec. 31, 2017	Dec. 31, 2016	Sep. 30, 2017	Sep. 30, 2016	Jul. 14, 2016
Interest Expense, Related Party		$ 37,390	$ 32,968	$ 143,917	$ 109,825
Interest Payable, Current		115,337		86,253	118,749
Strategic Capital Partners [Member]
Notes Payable, Related Parties		1,931,646		1,978,683	2,024,297	$ 2,431,646
Interest Expense, Related Party		37,390	$ 32,968	143,917	109,825
Interest Payable, Current		106,596		84,998	$ 109,825
Interest Paid		21,133		194,358
Strategic Capital Partners [Member] | Notes Payable Converted to Promissory Notes [Member]
Notes Payable, Related Parties		1,931,646		1,978,683		$ 1,931,646
Coastal Compassion Inc. [Member]
Working Capital Advances	$ 2,500,000
Working Capital Advances, Term	5 years
Note Receivable, Interest Rate	18.00%
Consulting Services Term	3 years
Consulting Services Revenue Monthly	$ 10,000
Coastal Compassion Inc. [Member] | Construction and Working Capital Advances [Member]
Due from Related Parties		131,589		125,327
Coastal Compassion Inc. [Member] | Construction and Working Capital Advances Excluding Accrued Interest [Member]
Due from Related Parties		119,635
Coastal Compassion Inc. [Member] | Construction and Working Capital Advances Related Accrued Interest [Member]
Due from Related Parties		11,954		5,692
Coastal Compassion Inc. [Member] | Maximum [Member]
Working Capital Advances	$ 2,500,000
Construction and Working Capital Advances [Member] | Construction and Working Capital Advances Excluding Accrued Interest [Member]
Due from Related Parties		$ 119,635		$ 119,635

Note 7 - Loss Per Share (Detail

Note 7 - Loss Per Share (Details Textual) - shares	3 Months Ended		12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Sep. 30, 2017	Sep. 30, 2016
Employee Stock Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	1,305,000	1,205,000	1,305,000	1,205,000
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	11,566,000	9,981,000	10,166,000	4,341,000

Note 7 - Loss Per Share - Sched

Note 7 - Loss Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($)	3 Months Ended		12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Sep. 30, 2017	Sep. 30, 2016
Net loss	$ (1,374,364)	$ (516,765)	$ (2,771,894)	$ (2,210,764)
Basic weighted average outstanding shares of common stock (in shares)	19,366,000	18,236,435	19,007,371	17,031,000
Dilutive effects of common share equivalents (in shares)	0	0	0	0
Dilutive weighted average outstanding shares of common stock (in shares)	19,366,000	18,236,435	19,007,371	17,031,000
Basic and diluted loss per common share (in dollars per share)	$ (0.07)	$ (0.03)	$ (0.15)	$ (0.13)

Note 8 - Income Taxes (Detail75

Note 8 - Income Taxes (Details Textual) - USD ($)	3 Months Ended
	Dec. 31, 2017	Sep. 30, 2017
Income Tax Expense (Benefit)	$ 0
Deferred Income Tax Assets, Net	0
Unrecognized Tax Benefits	$ 0	$ 0

Note 9 - Stock Based Compensa76

Note 9 - Stock Based Compensation (Details Textual) - USD ($) shares in Thousands	3 Months Ended		12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Sep. 30, 2017	Sep. 30, 2016
Allocated Share-based Compensation Expense			$ 37,450	$ 131,075
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized			$ 0
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number	0
Allocated Share-based Compensation Expense	$ 0	$ 18,725
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options	0
Employee Stock Option [Member]
Allocated Share-based Compensation Expense	0	$ 0
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized	$ 0

Note 9 - Stock Based Compensa77

Note 9 - Stock Based Compensation - Stock Option Activity (Details) - USD ($)	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2015
Shares Outstanding (in shares)	1,305,000	1,305,000	1,205,000	1,205,000
Outstanding, weighted average exercise price (in dollars per share)	$ 8.29	$ 8.29	$ 8.70	$ 8.70
Outstanding, weighted average contractual term (Year)	219 days	328 days	1 year 182 days	1 year 182 days
Outstanding, aggregate intrinsic value	$ 431,200

Note 10 - Commitments and Con78

Note 10 - Commitments and Contingencies (Details Textual)	Feb. 16, 2018USD ($)$ / sharesshares	Oct. 17, 2017USD ($)$ / sharesshares	Oct. 17, 2016USD ($)a$ / shares$ / itemshares	Apr. 07, 2016USD ($)	Jul. 31, 2014USD ($)a	Dec. 31, 2017USD ($)$ / shares	Dec. 31, 2016USD ($)	Sep. 30, 2017USD ($)$ / shares	Sep. 30, 2016USD ($)$ / shares	Sep. 30, 2016USD ($)$ / shares	Sep. 30, 2016USD ($)$ / shares	Dec. 12, 2017$ / shares	Dec. 04, 2017a	Sep. 30, 2015$ / shares	Jan. 14, 2015a
Area of Land | a					5								5
Payments to Acquire Land Held-for-use					$ 2,250,809
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares						$ 3.42		$ 3.68	$ 6.19	$ 6.19	$ 6.19			$ 8.92
Common Stock, Par or Stated Value Per Share | $ / shares						$ 0.0001		$ 0.0001	$ 0.0001	$ 0.0001	$ 0.0001
Operating Leases, Future Minimum Payments, Due in Two Years								$ 341,496
Operating Leases, Future Minimum Payments, Due in Three Years								341,496
Operating Leases, Future Minimum Payments, Due in Four Years								341,496
Operating Leases, Future Minimum Payments, Due in Five Years								341,496
Operating Leases, Office Space [Member]
Operating Leases, Rent Expense, Net								35,610	$ 35,145
Operating Leases, Monthly Payment						$ 1,845		2,920
Additional Paid-in Capital [Member]
Warrants Issued During Period, Value, Sale Leaseback Transaction			$ 1,972,966
Stock Issued During Period, Value, Sale Leaseback Transaction			73,000
Warrants Issued for Lease Amendment [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares		100,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares		$ 1.50
Warrants and Rights Outstanding						171,307
Warrants Issued for Lease Amendment [Member] | Subsequent Event [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares	50,000	100,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares	$ 1.50	$ 1.50
Sale Leaseback to MMP [Member]
Payments to Acquire Land			$ 925,000
Lessee, Operating Lease, Term of Contract			50 years
Lessee Leasing Arrangements, Operating Leases, Number of Renewal Periods			4
Lessee, Operating Lease, Renewal Term			10 years
Sale Leaseback Transaction, Monthly Rental Payments			$ 30,000
Sale Leaseback Transaction, Monthly Rental Payments, Per Square Foot | $ / item			0.38
Sale Leaseback Transaction, Monthly Rental Payments, Percentage of Gross Monthly Sales			1.50%
Sale Leaseback Transaction, Monthly Rental Payments, Adjustment Period			5 years
Sale Leaseback Transaction, Period Available to Obtain Capital Funding for Construction of the First Phase Building		1 year 120 days	180 days
Sales Leaseback Transaction, Amount of Capital Funding to Obtain For Construction of the First Phase Building		$ 2,600,000	$ 2,600,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares			3,640,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares			$ 1									$ 1
Sale Leaseback Transaction, Discount to the Purchase Price, Monthly Reduction in Payments			$ 1,542
Stock Issued During Period, Shares, Sale Leaseback Transaction | shares			100,000
Common Stock, Par or Stated Value Per Share | $ / shares			$ 0.0001
Sale Leaseback to MMP [Member] | Warrant [Member]
Fair Value Assumptions, Risk Free Interest Rate			1.12%
Fair Value Assumptions, Expected Term			4 years
Fair Value Assumptions, Expected Volatility Rate			115.00%
Sale Leaseback to MMP [Member] | Subsequent Event [Member]
Sale Leaseback Transaction, Period Available to Obtain Capital Funding for Construction of the First Phase Building	1 year 180 days	1 year 120 days
Sales Leaseback Transaction, Amount of Capital Funding to Obtain For Construction of the First Phase Building	$ 2,600,000	$ 2,600,000
Massachusetts Land Purchase [Member]
Area of Land | a			52.6												52.6
Payments to Acquire Land										$ 725,000	$ 925,000
Land, Selling Price			$ 4,475,000							$ 4,325,000
Payments to Acquire Land Held-for-use			$ 3,550,000
Operating Leases, Rent Expense, Net						108,625	$ 98,852	506,765	$ 0
Operating Leases, Future Minimum Payments, Remainder of Fiscal Year						256,122
Operating Leases, Future Minimum Payments, Due in Two Years						341,496
Operating Leases, Future Minimum Payments, Due in Three Years						341,496
Operating Leases, Future Minimum Payments, Due in Four Years						341,496
Operating Leases, Future Minimum Payments, Due in Five Years						341,496
Operating Leases, Future Minimum Payments, Due in Four and Five Years						15,026,024
Coastal Compassion Inc. [Member]
Working Capital Advances				$ 2,500,000
Working Capital Advances, Term				5 years
Note Receivable, Interest Rate				18.00%
Officer Employment Agreement, Initial Term				3 years
Consulting Services Revenue Monthly				$ 10,000
Coastal Compassion Inc. [Member] | Construction and Working Capital Advances [Member]
Due from Related Parties						131,589		125,327
Coastal Compassion Inc. [Member] | Construction and Working Capital Advances Excluding Accrued Interest [Member]
Due from Related Parties						119,635
Coastal Compassion Inc. [Member] | Construction and Working Capital Advances Related Accrued Interest [Member]
Due from Related Parties						$ 11,954		$ 5,692

Note 11 - Shareholders' Equit79

Note 11 - Shareholders' Equity (Details Textual) - USD ($)	Jul. 14, 2016	Dec. 31, 2017	Sep. 30, 2017	Sep. 30, 2016	Dec. 12, 2017	Sep. 01, 2017	Oct. 17, 2016	Sep. 15, 2016	Sep. 30, 2015
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 3.42	$ 3.68	$ 6.19					$ 8.92
Class of Warrant or Right, Granted During Period		1,400,000	5,825,000	1,750,000
Class of Warrant or Right, Granted During Period, Exercise Price		$ 1.50	$ 1.81	$ 2.14
Warrants to Purchase Additional Shares [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights				$ 1.25				$ 1.25
Strategic Capital Partners [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 1.50
Strategic Capital Partners [Member] | Warrants to Purchase Additional Shares [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 3
Fair Value Assumptions, Expected Term	4 years
Fair Value Assumptions, Expected Volatility Rate	100.00%
Fair Value Assumptions, Risk Free Interest Rate	0.96%
Fair Value Assumptions, Exercise Price	$ 3
Fair Value Assumptions, Expected Dividend Rate	0.00%	0.00%
Minimum [Member] | Strategic Capital Partners [Member] | Warrants to Purchase Additional Shares [Member]
Fair Value Assumptions, Expected Term		3 years
Fair Value Assumptions, Expected Volatility Rate		163.00%
Fair Value Assumptions, Risk Free Interest Rate		1.73%
Fair Value Assumptions, Exercise Price		$ 1.74
Maximum [Member] | Strategic Capital Partners [Member] | Warrants to Purchase Additional Shares [Member]
Fair Value Assumptions, Expected Term		5 years
Fair Value Assumptions, Expected Volatility Rate		176.00%
Fair Value Assumptions, Risk Free Interest Rate		2.00%
Fair Value Assumptions, Exercise Price		$ 4.09
Sale Leaseback to MMP [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights					$ 1		$ 1
Equity Line Agreement [Member]
Purchase Price of Weighted Average Price of Common Stock					90.00%	90.00%
Percentage of Closing Price of Common Stock					75.00%	75.00%
Mountain States Capital, LLC [Member]
Line of Credit Facility, Maximum Borrowing Capacity					$ 10,000,000	$ 10,000,000
Line of Credit Facility, Current Borrowing Capacity					$ 500,000	$ 500,000

Note 11 - Shareholders' Equit80

Note 11 - Shareholders' Equity - Warrant Activity (Details) - USD ($)	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2015
Outstanding, warrants (in shares)	10,166,000	4,341,000	2,591,000
Outstanding, warrants, weighted average exercise price (in dollars per share)	$ 3.68	$ 6.19	$ 8.92
Outstanding, warrants, weighted average remaining contract term (Year)	2 years 146 days	2 years 146 days	2 years 36 days	2 years 255 days
Granted, warrants (in shares)	1,400,000	5,825,000	1,750,000
Granted, warrants, weighted average exercise price (in dollars per share)	$ 1.50	$ 1.81	$ 2.14
Granted, warrants, weighted average remaining contract term (Year)	4 years 292 days	3 years 36 days	3 years 292 days
Outstanding, warrants (in shares)	11,566,000	10,166,000	4,341,000	2,591,000
Outstanding, warrants, weighted average exercise price (in dollars per share)	$ 3.42	$ 3.68	$ 6.19	$ 8.92
Class of warrant or right, outstanding, aggregate intrinsic value	$ 20,461,100	$ 3,756,000
Vested and expected to vest, warrants (in shares)	11,566,000	10,166,000
Vested and expected to vest, warrants, weighted average exercise price (in dollars per share)	$ 3.42	$ 3.68
Vested and expected to vest , weighted average remaining contract term (Year)	2 years 146 days	2 years 146 days
Class of warrant or right, vested and expected to vest, aggregate intrinsic value	$ 20,461,100
Exercisable, warrants (in shares)	7,826,000	6,526,000
Exercisable, warrants, weighted average exercise price (in dollars per share)	$ 5.50	$ 5.18
Exercisable, warrants, weighted average remaining contract term (Year)	2 years 73 days	2 years
Class of warrant or right, exercisable, aggregate intrinsic value	$ 8,954,500	$ 480,000

Note 12 - Subsequent Events (De

Note 12 - Subsequent Events (Details Textual) - USD ($)	Feb. 16, 2018	Jan. 18, 2018	Oct. 17, 2017	Oct. 17, 2016	Feb. 12, 2018	Dec. 31, 2017	Dec. 29, 2017	Dec. 12, 2017	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2015
Class of Warrant or Right, Exercise Price of Warrants or Rights						$ 3.42			$ 3.68	$ 6.19	$ 8.92
Sale Leaseback to MMP [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights				3,640,000
Class of Warrant or Right, Exercise Price of Warrants or Rights				$ 1				$ 1
Sale Leaseback Transaction, Period Available to Obtain Capital Funding for Construction of the First Phase Building			1 year 120 days	180 days
Sales Leaseback Transaction, Amount of Capital Funding to Obtain For Construction of the First Phase Building			$ 2,600,000	$ 2,600,000
Warrants Issued to Accredited Investors [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights							533,333
Class of Warrant or Right, Exercise Price of Warrants or Rights							$ 1.50
Warrants Issued for Lease Amendment [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights			100,000
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 1.50
Subsequent Event [Member] | Sale Leaseback to MMP [Member]
Sale Leaseback Transaction, Period Available to Obtain Capital Funding for Construction of the First Phase Building	1 year 180 days		1 year 120 days
Sales Leaseback Transaction, Amount of Capital Funding to Obtain For Construction of the First Phase Building	$ 2,600,000		$ 2,600,000
Subsequent Event [Member] | Warrants Issued to Accredited Investors [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights					540,000
Class of Warrant or Right, Exercise Price of Warrants or Rights					$ 1.50
Subsequent Event [Member] | Warrants Issued for Lease Amendment [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	50,000		100,000
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 1.50		$ 1.50
Subsequent Event [Member] | Accredited Investors [Member] | Construction Loans [Member]
Debt Instrument, Face Amount					$ 810,000
Debt Instrument, Interest Rate, Stated Percentage					8.00%
Debt Instrument, Convertible, Conversion Price					$ 1.50
Subsequent Event [Member] | Demand for Arbitration against WGP [Member]
Litigation Settlement, Amount Awarded from Other Party		$ 1,045,000
Litigation Settlement, Amount Awarded Receivable from Other Party, Interest Rate		18.00%
Litigation Settlement Interest		$ (523,023)
Litigation Settlement, Amount Awarded from Other Party, Including Interest		$ 1,568,023